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ABSTRACT
The purpose of this investigation was to examine
selected biochemical mechanisms known to influence con-
tractility and energy metabolism in the myocardium, with
particular emphasis placed on the regulatory role of
protein phosphorylation in the ventricular myocardium.
The investigation was conducted in three phases; initially
the cardiac contraction cycle was examined to determimine
whether reported fluctuations in myocardial cAMP levels
were associated with other biochemical events known to be
cAMP-dependent. The second phase involved the determina-
tion of specific kinase activities and endogenous sub-
strates in a highly purified cardiac sarcolemmal prepara-
tion. In the final phase , ventricular myocytes were uti-
lized to examine the ability of adenosinergic and musca-
rinic agonists to influence the isoproterenol- induced
increases in protein phosphorylation.
Studies in the first phase examined cyclic AMP
levels and selected kinase activities in hearts frozen at
various stages of the cardiac cycle. An automated clamp-
ing device , capable of freezing a perfused rat heart in
less than 50 msec , was utilized to separate the cardiac
cycle into various phases. Three different timing schemes
were employed to divide the cycle into 2 to 4 segments.
These different timing schemes revealed no significant
differences in cAMP during the cardiac cycle. Myocardial
cAMP values ranged from 2. 5 to 4. 1 pmol/min/mg protein in
all phases. However , in one scheme there was a tendency
for cAMP to be elevated in early systole , with minimal
values occurring diastole. There were also no significant
differences seen for either glycogen phosphorylase or
cAMP-dependent protein kinase (PKA) activity between
var ious phases of the cardiac cycle. since no significant
fluctuations were observed in the levels of cAMP or the
acti vi ties of PKA or glycogen phosphorylase during a
single cardiac contraction cycle , it would appear that
these agents do not exert their effects on cardiac func-
tion on a beat to beat basis.
The second phase of study examined the nature and
function of individual protein kinases in the myocardium.
Using a highly purified cardiac sarcolemmal preparation
kinase specific , synthetic substrates were employed to
quantify the activities of cAMP-dependent (PKA),
calcium/calmodulin-dependent (PKCM),
calcium/phospholipid-dependent (PKC) and cGMP-dependent
(PKG) protein kinases. Additionally, endogenous protein
substrates were examined in this preparation to provide
possible insight as to the function of these kinases in
the heart. The activities of PKA , PKG , PKCM , and PKC in
nmol 32P/min/ g protein were as follows: PKA , 1606; PKG
35. 7; PKCM , 353; and PKC , 13. Three endogenous protein
substrates of apparent molecular weights of 15kD , 28kD and
92kD were phosphorylated. While no endogenous protein
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phosphorylation was detectable as a result of cG-PK act iv-
ity, all of the substrates were phosphorylated , to varying
degrees , by both PKA and CACM-PK. PKC phosphorylated
only the 15kD substrate.
Even though several endogenous kinases are vident
in the sarcolemmal preparation , cAMP-dependent protein
kinase demonstrates the greatest degree of acti vi ty. This
kinase also appeared to be the most abundant; however
there is some concern as to the source of these kinases in
the membrane preparation since endothelial membranes as
well as cardiac membranes appeared to be present. Evi-
dence for endothelial contamination was provided by the
finding that the membrane preparation contained apprecia-
ble amounts of angiotensin converting enzyme (ACE) activi-
ty, an enzyme felt to reside in the vascular endothelium.
since studies with this preparation could not exclude
contribution of nonmuscle cell membranes a model consist-
ing solely of dispersed ventricular myocytes was de-
veloped.
The third phase of these studies examined protein
phosphorylation in primary cultures of ventricular myo-
cytes. specifically, these studies examined protein
phosphorylation induced by exposure to isoproterenol
(ISO), a catecholamine known to effect changes in the
phosphorylation state of proteins in the heart by means of
a B-adrenergic-mediated/ cAMP-dependent mechanism was
examined. Additionally, the effects of phenylisopropy-
viii
ladenosine (PIA) and carbamyl choline chloride (CARB) were
examined with regard to their anti-adrenergic role(s)
this process.
Adherent , collagenase-dispersed , radiolabelled ( 3 2
ventricular myocytes exposed to ISO demonstrated a dose
and time dependent increase in 32p incorporation into
several endogenous protein substrates. When the myocytes
were exposed (60 sec) to either PIA or CARB prior to the
exposure to ISO , ISO-induced 32p incorporation into pro-
tein substrates of apparent molecular weight of 6kD , 31kD
and 155kD was reduced up to 67% when compared to the
effects of ISO alone. Additionally, both PIA and CARB
attenuated the ISO-induced increase in PKA activity in the
myocyte , yet only CARB was seen to produce an inhibitory
effect on the ISO-induced increase in cAMP levels in the
myocytes. The effects of CARB were dose-dependent and
inhibited the effects of ISO on 32p incorporation at all
doses tested. PIA elicited biphasic effects: lower PIA
concentrations were inhibitory in nature , while higher
concentrations of PIA appeared to potentiate the increase
in 32p incorporation induced by ISO. Based on electropho-
retic mobilities (SDS/PAGE) of the 6kD and the 155kD
substrates , these substrates have been tentatively identi-
fied as the monomeric form of the sarcoplasmic reticulum-
associated protein , phospholamban , and the contractile
filament-associated protein , C protein , respectively. The
31kD substrate has been identified , by means of immuno-
blot, as the contractile filament-associated protein
troponin I.
The role of protein phosphorylation in the myocardi-
um involves complex , inter-related mechanisms that encom-
pass extracellular , transmembranal and cytoplasmic ele-
ments in the heart. It is well understood that certain
mechanisms of the contraction cycle known to vary on a
beat to beat basis , such as myosin ATPase , involve changes
in protein phosphorylation. However , the nature of the
various kinases and substrates examined in this study
appear to influence longer-term events of myocardial
contractili ty. Mechanisms coupled with hormone action
modulation of second messenger-dependent components , and
factors associated with changes in contractility seen with
aging and disease are more likely to exhibit changes
similar to those described herein. A better understanding
of the underlying biochemistry may provide greater insight
into the importance of these metabolic changes.
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CHAPTER I
INTRODUCTION
The unique , all or nothing, manner of myocardial
contraction dictates that the regulation of contractile
function in the heart relies primarily on internal bio-
chemical mechanisms. An integral component of these
mechanisms is the close control and coordination of the
intracellular levels of calcium and CAMP , as well as the
activity of protein kinases and the phosphorylation state
of several proteins in the ventricular myocyte.
The cyclic oscillation of certain events in the
myocyte is suggested by the regular and repetitive nature
of cardiac contraction. Although the variation in calcium
levels over a single contraction cycle in the myocyte has
been well established (83), evidence for the cyclic varia-
tion of additional elements is not as distinct. It has
been suggested that the intracellular levels of cAMP , ATP
creatine phosphate , glucose-6-phosphate , and lactate , as
well as the activity of the enzyme , glycogen phosphory-
lase , vary over the course of a single contraction cycle
( 141) . However , the rigorous confirmation of these varia-
tions are , to date , somewhat limited by available experi-
memtal techniques necessary to directly assess these
var iables .
Extrinsic control of the heart is provided by the
autonomic nervous system, with B-adrenergic (positive) and
cholinergic (negative) neurotransmitters influencing
contractile state. These extrinsic factors are involved
more with the myocardial response to stress. In contrast
intrinsic control mechanisms , generally described by
starling I s Law are primarily concerned with the basal
acti vi ty of the heart.
Given the unique manner of contraction in the myo-
cardium and the apparent roles of protein phosphorylation
and the intracellular concentrations of cAMP and calcium
to this process , the following questions were proposed for
investigation.
Can we detect fluctuations in intracellular cAMP
and/or in cAMP-dependent processes during a single
contraction cycle in the perfused heart?
What are the relative activities of cAMP-depend-
ent , cGMP-dependent , calcium/calmodulin-dependent
and calcium/phospholipid-dependent protein kinases
in the sarcolemma , and what are their endogenous
protein substrates?
since cholinergic and adenosinergic agonists are
known to antagonize the positive inotropic effects
of adrenergic agonists in the heart , can we explain
the antagonistic actions of these agents at the
level of cAMP production , activation of PKA and/or
changes in the phosphorylation of protein substrates
in ventricular myocytes? pa
While the fiber length of the myocardium is the
primary determinant of the strength of contraction of the
heart , sympathetic stimulation can enhance contractile
state. This manner of stimulation occurs predominantly by
activation of myocardial B-adrenergic receptors. Early
investigations in the heart and other tissues demonstrated
that cAMP levels increased in response to exposure to
catecholamines (128 129). Although phosphorylation was
known to regulate the acti vi ty of glycogen synthase and
phosphorylase kinase (39 80), the link between cAMP eleva-
tion and protein kinase activation was only established by
the demonstration of a cAMP-dependent protein kinase
(137) . wi th the subsequent demonstration of the role of
troponin and myosin as substrates for protein kinases
(104 126), the significance of protein phosphorylation for
regulation of cardiac function was established.
Concomitant with the emergence of the critical role
of protein phosphorylation in the heart was the apprecia-
tion of the second messenger roles of cAMP and calcium
(110). The potential feedback mechanisms in the control
of calcium and cAMP , and the appreciation of specific
events dependent upon these agents , suggests an interac-
tion between regulatory pathways involving these second
messengers.
Contraction in the ventricular myocyte is dependent
upon the level of intracellular calcium. As the wave of
depolarization reaches the myocyte during excitation-
contraction coupling in the myocardium, calcium flows into
the cell , in turn triggering the release of additional
calcium stored in the sarcoplasmic reticulum. In this
calcium-induced calcium release process intracellular
calcium concentrations are raised from diastolic levels of
less than 10 M to levels on the order of 10 (35) .
Calcium is then available to bind to a subunit of troponin
(TNC), an action that relieves the inhibition of tropomy-
osin by troponin. This permits crossbridge formation
between actin and myosin and the activation of a myosin
ATPase , with the subsequent shortening of the muscle fiber
(83). Relaxation at the level of the individual myocyte
invol ves the reduction of intracellular calcium levels by
resequestration into the sarcoplasmic reticulum and extru-
sion into the extracellular space (113). This reduction
is brought about by calcium pumps in the sarcolemma and in
the sarcoplasmic reticulum.
The interdependent nature of contractile regulation
upon these second messengers is evident since the movement
of calcium during the contraction cycle is modulated by
cAMP-dependent mechanisms (136) and since phosphorylase
kinase , a cAMP-dependent enzyme involved in glycogenoly-
sis, has a distinct requirement for calcium (96). with
an appreciation of the link between glycogen metabolism
and cardiac contraction (54), and the role of protein
phosphorylation in modulating these events , the mechanisms
involved in controlling cellular levels of these second
messengers has been the focus of a large body of investi-
gat ion in the field of cardiovascular physiology.
nalin Pathwa for B-Adrener ic A ents. Membrane
associated adenylyl cyclase catalyses the conversion of
ATP to cAMP in the myocyte ( 35) . This cytoplasmic face
enzyme system is linked to the extracellular compartment
via a transmembrane signaling system and is responsive to
circulating catecholamines. The B-adrenergic receptor is
coupled to adenylyl cyclase through the GTP-binding pro-
tein, G (42). Also associated with this complex is
another group of GTP-binding proteins , designated G
which serves to inhibit cyclase acti vi ty when acetylcho-
line and adenosine bind to muscarinic (M2) and adenosiner-
gic (Ai)' respectively (55 116). When elevated , cAMP
serves to activate membrane-associated kinases as well as
soluble enzymes (14). The degradation of cAMP occurs via
hydrolysis by phosphodiesterases (PDE). Several types of
phosphodiesterases exist in the myocyte with sensitivities
to calcium/calmodulin or cGMP (95). Thus , the increase in
calcium in response to B-adrenergic stimulation activates
phosphodiesterase to limit the action of cyclic nucleo-
tides.
Intracellular Domains and Protein Phos hor lation Sarco-
1 emma. Inotropic state in the heart is most likely a
function of calcium levels in the myocyte , with both
myofibrillar sensitivity and myofibrillar exposure to the
calcium playing significant roles. since free calcium
levels in the cytoplasm range from 10 M to 10 , while
extracellular levels of the ion are near 10 M (35), 
is apparent that the sarcolemma must play an important
role in the control of calcium flux in the myocyte. There
is a considerable burden on the cell to maintain proper
calcium levels. This is evidenced by the sizable extra-
cellular to intracellular concentration gradient , coupled
wi th the large change in cytoplasmic calcium concentration
during the contraction cycle. From diastole to systole
the increase from 10 M to 10 M is due to an influx of
calcium via the slow calcium channels in the sarcolemma
and a release of calcium from the sarcoplasmic reticulum
(30) . At the level of the sarcolemma , this calcium
burden is cleared using two different mechanisms. The
majority of the calcium is removed from the myocyte by
means of a sodium-calcium exchanger (Na+ -Ca2+ antiporter)
resident in the sarcolemma. Calcium is also removed from
the myocyte by an ATP dependent calcium pump. Wi th the
greater sensitivity for calcium shown by the calcium pump,
it is felt that diastolic levels of calcium are maintained
by this system. The antiporter is felt to be operative
during systole (113). It has been reported that calcium
influx through the slow channel is enhanced by cAMP-de-
pendent protein kinase (102), presumably by phosphoryla-
tion of a channel-associated protein. Additionally ,
calcium or cAMP-dependent phosphorylation is felt to
enhance the velocity (Vmax) of the ATP-dependent calcium
pump, with no apparent effect on the Na+ -ca2+ antiporter
(15) . Additional support for the role of protein kinase
and phosphorylation in the regulation of calcium flux is
provided by the catecholamine-enhanced increase in slow
inward channel acti vi ty being reduced in the presence of
muscarinic (132) or adenosinergic (120) agonists. The
antiadrenergic actions of these agents are associated with
reduction in cAMP-dependent protein kinase activity (21)
and the reduction in the phosphorylation of protein sub-
strates (36). Therefore , at the level of the sarcolemma
both calcium and cAMP-dependent processes may be involved
in the mechanisms associated with an increase in inotropic
state.
Sarco lasmic Reticulum. Coupled with extracellular calci-
um as a source for increasing cytoplasmic levels of the
ion is the calcium stored in the sarcoplasmic reticulum.
This network of tubules surrounds the myofibrils of the
sarcomere and is in contact with the invaginations of the
sarcolemma making up the T tubule system (130). It is
felt that the initial calcium flux triggered by the depo-
larization of the myocyte induces the release of the
calcium stored in the sarcoplasmic reticulum, bathing the
myofibrils in calcium and promoting contraction by modify-
ing the interaction between the regulatory components
(troponin) of the contractile proteins (127). Dur ing
relaxation , the calcium is resequestered into the sarco-
plasmic reticulum by active transport via another Ca
-ATPase (.130). Phospholamban , a protein associated
with the ATPase of the sarcoplasmic reticulum , has been
shown to be phosphorylated by cAMP-dependent protein
kinase and calcium/calmodulin-dependent protein kinase
( 139) . The increase in time to peak tension development
and rate of relaxation produced by isoproterenol in the
heart may be correlated with phospholamban phosphorylation
(86) . An increase in phosphate incorporation into phos-
pholamban by cAMP-dependent protein kinase corresponds
wi th an increase in calcium transport into the sarcoplas-
mic reticulum (76) which can effect both the rate of
calcium removal and the amount of calcium stored. Thus
the increased rate of relaxation produced by isoproterenol
stimulation may be due to the more rapid resequestration
of calcium into the sarcoplasmic reticulum caused by the
increased phosphorylation state of phospholamban; and the
increased rate of tension development may be a result of
the greater release of calcium from the sarcoplasmic
reticulum.
Contractile Proteins. Calcium produces a change in the
interaction of the contractile proteins , myosin and actin
and the regulatory proteins associated with these elements
in the sarcomere. While the light chain subunits of
myosin appear to be substrates for calcium/calmodulin-
dependent protein kinase in vitro , no apparent physiologi-
cal role for this phosphorylation has been demonstrated in
cardiac muscle (60). protein , a protein associated
with the myosin complex , has been shown to be a substrate
for cAMP-dependent protein kinase; and , the change in
phosphorylation of this protein correlates with an in-
crease in myofibrillar Ca -ATpase activity and an in-
crease in inotropic state. The dephosphorylation of this
protein does not correspond temporally with the removal of
catecholamine stimulation (47); Thus the function of this
protein is unclear. other proteins associated with the
sarcomere may be modulated by phosphorylation. For exam-
pIe , the troponin complex (troponin I , T, C) is involved
wi th the tropomyosin molecule in the regulation of actin
and myosin interaction (127). Troponin C possesses three
calcium binding sites , two being high affinity sites that
are occupied at the low calcium concentrations seen in
diastole. As the calcium concentration increases during
systole , the third , low affinity calcium site on troponin
C becomes occupied , increases the affinity of troponin C
for troponin I and induces a steric shift in the molecules
exposing the myosin binding site on the actin filament
thereby permitting interaction with the myosin filament.
with actin and myosin able to more freely interact con-
traction occurs. Troponin I has been shown to be a sub-
strate for cAMP-dependent protein kinase (32). This
increase in phosphorylation state is associated with a
decrease in sensitivity for myofibrillar calcium binding
(111). And it has been postulated that this alteration in
calcium affinity is responsible for the increased rate of
relaxation seen with catecholamine stimulation (70).
en Particle. The contractile process relies on
precise metabolic control to provide the requisite energy
for contraction. An important source of energy in the
myocyte is glycogen and glycogenolysis is regulated by a
series of multiple and interdependent enzymatic reactions
(54) .
adrenergic stimulation leads to an activation of
glycolysis in 2 ways: 1. by stimulating phosphorylation of
phosphorylase kinase , a process mediated by B-adrenergic
acti vat ion of adenylyl cyclase , increased levels of cAMP
and increased acti vi ty cAMP-dependent protein kinase and
2. increased calcium availability, a process involving 
adrenergic actions to increase calcium stored and increase
calcium channel activity (94).
The role of protein phosphorylation is evident in
the precise coordination within the cascade of cAMP-de-
pendent events. The activation of glycogen phosphorylase
by phosphorylation is accompanied by the concomitant
inactivation of glycogen synthase by phosphorylation; and
the control of opposing metabolic processes is achieved by
one signaling mechanism.
Control of Phos hor lation. Protein kinases associated
with the majority of phosphorylations taking place in the
heart may be categorized as cyclic nucleotide-dependent or
calcium-dependent. Most of the actions of catecholamines
in the heart are mediated by cAMP-dependent protein kinase
(PKA) . This enzyme exist as in two isoforms in the heart
with the predominant type varying with species , however
there are no apparent differences in the substrate speci-
ficity for the two isoforms (49). PKA exists in both the
soluble and particulate fractions of the heart , with half
maximal activation of the enzyme occurring at a cAMP
concentration of 1. 0 ~M (48). A second cyclic nucleo-
tide-dependent protein kinase , cGMP-dependent protein
kinase, is activated by muscarinic stimulation of the
heart. Substrates unique to cGMP-dependent protein kinase
have not been identif ied; and although able to phosphory-
late substrates of PKA , the kinetic parameters of these
enzymes are such that it is unlikely that phosphorylation
of these substrates by cGMP-dependent protein kinase
occurs in vivo (61).
Calcium-dependent protein kinases may be separated
into two categories: calcium/calmodulin-dependent and
calcium/phospholipid-dependent. Phosphorylase kinase , a
key enzyme in the glycogenolytic pathway, is activated by
calcium. Al though phosphorylation of this enzyme by PKA
slightly increases its affinity for calcium , it is the
binding of calcium to the calmodulin subunit of the enzyme
that activates this kinase. Once activated , this kinase
converts glycogen phosphorylaseQ to by phosphorylation
(54) . Myosin light chain kinase (MLCK) is also activated
by its formation of a ternary complex with calcium and
calmodulin. In smooth muscle , MLCK increases myosin
ATPase activity; however in the heart , myosin light chain
phosphorylation does not affect myosin ATPase activity and
its function is at present unclear (59). Initially iso-
lated in the brain (131), calcium/phospholipid-dependent
protein kinase (PKC) has been characterized at low levels
in the heart (81). PKC , in common with other kinases
phosphorylates a number of substrates such as troponin I
troponin C , myosin light chains , phospholamban and several
sarcolemmal proteins. In addition this enzyme phosphory-
lates several unique substrates (5). Al though a clear
role for PKC has not been identified , it may function in a
modulatory manner with regard to the actions of other
enzymes.
since covalent modification by protein phosphoryl 
tion is considered to provide a regulatory function, a
counteracting mechanism (s) must exist to modulate this
type of control process. Phosphoprotein phosphatases have
been associated with the dephosphorylation of various
substrates in the heart. Protein phosphatase-1 and -2 are
associated with glycogen metabolism , with phosphatase-1
associated with the glycogen particle and responsible for
approximately 80% of the phosphatase activity. Phospha-
tase 1 dephosphorylates glycogen phosphorylase , glycogen
synthase and phosphorylase kinase , thereby promoting a
down regulation of glycogenolysis (19). Phosphatase
inhibitor proteins (IP1 and IP2) regulate the activity of
phosphatase-1 (96). The phosphorylation of IP1 by PKA
resul ts in an inhibition of phosphatase- 1 acti vi ty and
demonstrates the high degree of coordination between
events involved in the energy metabolism of the heart.
Phosphatases involved in the dephosphorylation of myofi-
brillar proteins are less well characterized. Myosin
light chain phosphatase , as well as the phosphatase(s)
associated with the dephosphorylation of troponin I have
been characterized only to the extent that they vary in
reaction kinetics and type of response to hormonal stimu-
lation (99).
ulation of Contractilit and Gl enol sis. adre-
nergic agents have been shown to produce marked increases
in inotropic state and glycogenolytic activity (8) in the
heart. Through the elevation of cAMP and the increased
activity of PKA , the B-adrenergic challenged heart in-
creases cytosolic calcium levels during systole , more
rapidly eliminates calcium during diastole (83) and
increases the rate of glycogen breakdown (13) to fuel the
higher metabolic demands of the heart under stress.
The role of protein phosphorylation in the control
of the inter-related events during B-adrenergic stimula-
tion of the heart involves both the activation and inhibi-
tion of several processes. While troponin I , phospholamban
and a 15 kD protein associated with the slow inward calci-
um channel are phosphorylated to enhance contraction (77),
glycogen synthase and a phosphoprotein phosphatase inhibi-
tor protein are phosphorylated to inhibit their respec-
tive roles in glycogen synthesis and dephosphorylation of
certain proteins (100). Additionally, the calcium sensi-
tivity of myosin ATPase and phosphorylase kinase are
regulated by cAMP-dependent phosphorylation (40).
onist S ecif ici t However , other agents that act by
increasing cAMP levels in the heart and by activating
cAMP-dependent protein kinase do not always produce the
changes in contractile state associated with B-adrenergic
stimulation. The di terpene , forskolin , and prostaglandin
1 (PGE1) both elevate cAMP levels and PKA activity in the
heart (13). The elevation of cAMP levels in the perfused
heart caused by forskolin are 2 to 3 times greater than
the elevation produced by the B-adrenergic agonist , iso-
proterenol , yet the changes in contractility (+dP/dt) and
in PKA activity were similar to those changes seen with
isoproterenol. PGE1 produced no change in contractile
state despite producing an increase in cAMP and PKA acti 
i ty in the perfused heart (52). Examination of intracel-
lular compartments by fractionation studies , indicates
that the cAMP elevation associated with the particulate
component of the cell is required to activate a membrane
associated PKA , which then dissociates to the cytoplasm
(53) . It has been proposed that B-adrenergic agents
preferentially activate this subcellular component of
PKA .pawhich has access to specific co-factors or
substrates associated with increased contractility (14).
Antiadrener ic Effects in the Heart While adrenergic
stimulation of the heart is the predominant method of
increasing inotropic state , cholinergic stimulation pro-
duces an inhibitory or antiadrenergic effect on the ca-
techolamine stimulated heart (56). Adenosine also inhib-
its B-adrenergic actions in a manner that closely resem-
bles the antiadrenergic effects of acetylcholine (22).
The effects of both of these antiadrenergic agents may be
seen as a reduction in pressure generation , a decrease in
the catecholamine-enhanced acti vi ty of several enzymes in
the glycolytic pathway, a reduction in the catecholamine-
induced phosphorylation of protein substrates and a de-
crease in the catecholamine-stimulated levels of adenylyl
cyclase activity and cAMP production (36 88).
The significance of acetylcholine and adenosine
effects may in part be related to their continued presence
in the myocardium. Acetylcholine is continually released
by vagal nerves to the heart. Adenosine , present as a
metabolite in the intracellular and extracellular compart-
ment is continually produced. Additionally, adenosine
levels increase in response to ischemia , hypoxia and the
presence of endogenous catecholamines in the myocardium
(36) . Acetylcholine and adenosine reduce the electrophys-
iOlogic changes associated with catecholamine stimulation
of the heart (140).
Antiadrener ic Mechanisms The manner by which these
antiadrenergic agents attenuate catecholamine- induced
events in the heart is unclear. However it appears that
both muscarinic and adenosinergic receptors that are
inhibi tory with respect to adenylyl cyclase in the heart
ar.e coupled to the enzyme by an inhibitory version of the
nucleotide binding protein , G (115). This is supported by
the effects of both these antiadrenergic agents being
sensitive to pertussis toxin (55). Therefore , antiadrener-
gic agents may provide an inhibitory signal to the cyclase
at the same time that B-agonists are providing a stimula-
tory signal, with the balance being a reduced signal.
addition to the inhibitory Ai adenosinergic receptor
there exists an A2 receptor which is stimulatory toward
adenylyl cyclase (116). This receptor , while less sensi-
tive to adenosine than the Ai receptor will enhance adeny-
lyl cyclase activity in the heart at adenosine concentra-
tions above micromolar (22).
Phosphatase activity is also modulated. These
enzymes reverse the actions of adrenergic agents stimula-
tion , and act to limit the influence of B-adrenergic
agents on inotropic state (28). Thus a neurotransmitter
acetylcholine , and a local metabolite , adenosine , both
produce similar effects using common and different path-
ways.
Metabolic Oscillations Durin the Contraction C cle The
cyclic nature of events associated with cardiac contrac-
tion suggests oscillation (s) of certain metabolic events.
The level of intracellular calcium increases from diastole
to systole through an increased inflow through voltage
sensi ti ve calcium channels , coupled with the release of
calcium from the sarcoplasmic reticulum. Calcium levels
are returned to diastolic concentration by the actions of
calcium ATPases on the sarcolemma and the sarcoplasmic
reticulum. Elements of the contractile apparatus , such as
troponin and myosin ATPase , appear to vary in acti vi ty 
a function of the cross-bridge cycle (118). Additionally,
compounds involved in metabolic pathways , such as ATP
glucose-6-phosphate , lactate and creatine phosphate , as
well as cyclic nucleotides (cAMP and cGMP) and glycogen
phosphorylase have been reported to vary in concentration
during the cardiac cycle (38 141).
Some of the oscillations that occur during a cardiac
cycle , such as the variability in calcium flux through the
slow channels , are evident. However , other potential
cyclic oscillations such as with cAMP , have not been
clearly demonstrated. The role of intracellular compartmen-
talization has been offered in explanation for activation
of some but not all steps in a pathway, such as with the
cAMP-dependent cascade ( However , evidence for such
compartments , although attractive , is not readily
available. Additionally, the role of protein phosphoryla-
tion in this process in the heart is not completely clear.
The phosphorylation of certain proteins can be directly
correlated to contractile related events , yet many of the
phosphorylations occurring with B-adrenergic stimulation
of the heart have not been ascribed a physiological role.
Modulation of Contractile state since the contractile
state of the myocardium is dependent upon the concentra-
tion of calcium available to the myofilaments , as well as
the sensitivity of the myofilaments to calcium , mechanisms
affecting the availability of calcium would be likely
si tes for inotropic modulation. with the slow inward
calcium channel providing entry of calcium into the cell
to the point of triggering the release of calcium by the
sarcoplasmic reticulum (35), the sarcolemma can be viewed
as an initial level of control. adrenergic stimulation
results in an increase in the calcium slow current
(31 72). A protein that co-purifies with the slow- inward
calcium channel is phosphorylated by B-adrenergic activa-
tion of cAMP-dependent protein kinase and is believed to
influence the slow channel in a manner to increase calcium
f lux (124). Cholinergic agonists , known to attenuate 
adrenergic effects in the heart , reduce both the adrener-
gic stimulation of the slow channel and the possible
phosphorylation of this " channel-associated" protein
(125) . To expel the calcium accumulated in the sarcoplasm
during systole , the sarcolemma utilizes the sodium/calcium
exchanger and .a high aff ini ty, low capacity calcium/ATPase
(16) . The bulk of the calcium expelled from the myocyte
is due to the exchanger , a process not felt to be regulat-
ed by phosphorylation. However , the calcium/ATPase may
display an increased Vmax upon phosphorylation by either
cAMP-dependent or calcium-dependent kinases (57).
The release of calcium from the sarcoplasmic reticu-
lum is triggered by the increased calcium entering the
myocyte through the sloW inward channel. While phosphory-
lation does not directly alter elements of the sarcoplas-
mic reticulum involved in calcium release , cAMP-dependent
phosphorylation of phospholamban can impact the sarcoplas-
mic reticulum by altering the reuptake of calcium (76).
This phosphorylation correlates with the increased rate of
relaxation seen with B-adrenergic stimulation (124) and is
consistent with the greater calcium release by the sarco-
plasmic reticulum during B-adrenergic stimulation. since
phospholamban is closely associated with the
calcium/ATPase of the sarcoplasmic reticulum , phospholam-
ban phosphorylation may influence the activity of this
ATPase. Both the rate of calcium resequestration and the
degree of protein phosphorylation are attenuated by anti-
adrenergic agents such as acetylcholine (63).
The contractile apparatus of the sarcomere is sub-
j ect to modulation by phosphorylation at both the level of
the contractile and regulatory proteins (66). A light
chain associated with the head region of the myosin fila-
ment is a substrate for calcium/calmodulin-dependent
myosin light chain kinase; however the physiological role
of this phosphorylation is unclear (60). protein , a
150, 000 kD protein postulated to have structural signifi-
cance in the junctional region between the head and the
tail regions of the myosin filament (46), is a substrate
for cAMP-dependent protein kinase and is phosphorylated in
the heart following B-adrenergic stimulation (40).
At the level of the thin filament , regulation of the
troponin-tropomyosin complex may involve phosphorylation
of several proteins. The normal inhibitory role of tropo-
nin I regarding the calcium affinity of troponin C is
enhanced by phosphorylation (111). since the phosphoryla-
tion of troponin I correlates with the increase in ino-
tropic state seen during B-adrenergic stimulation , it is
speculated that the decrease in troponin C affinity for
calcium caused by TNI phosphorylation may underlie the
increased rate of relaxation (70).
erimental Models. Most investigation into cardiac
metabolism has been performed on the perfused heart. This
model offers the ability to correlate a change in contrac-
ti Ie function to a change in a biochemical event. Howev-
, the perfused heart as an experimental model poses
problems related to the heterogeneity of cell types
present in the preparation , coupled with the high levels
of isotope required for examination of phosphorylation
related investigations. The problem of one heart provid-
ing only one exper iment further compromises the perfused
heart as a model.
Isolated Ventricular M tes. Over the past decade the
use of isolated cardiac myocytes has provided the ability
to examine metabolic events in the cardiac cells directly.
The isolated cells permit multiple experiments from one
heart , the use of lower amounts of radioactivity than with
the perfused heart model and precise control of experimen-
tal conditions (142).
Cells are dispersed using several different treat-
ments in which varying amounts of collagenase and hyaluro-
nidase and other compounds are included. These myocytes
may then be employed in one of 3 ways , as freshly dis-
persed cells in suspension , as primary cultures or as long
term cultures. since myocytes consist of both viable
cells and damaged cells the results from studies using
freshly dispersed cells in suspension may be compromised
by the response of damaged cells. Long term culture of
myocytes provides the ability to perform chronic studies
however several weeks in culture are required for the
necessary transformation or redifferentiation to a cell
that metabolically resembles a cardiac myocyte (64).
the other hand the primary cultured myocyte retains the
morphology of the striated cardiomyocyte and exhibits
pharmacological and contractile behavior similar to the
whole organ.
The contractility of the isolated myocyte has been
examined under different experimental conditions. In-
creases in extracellular calcium produce an increase in
the rate and frequency of spontaneous contraction , while
field stimulation produces a reversible contraction of the
myocyte ( 75) . adrenergic stimulation of the isolated
myocyte produces an increase in rate and frequency of
contraction , changes in protein phosphorylation , enzyme
and ion channel activities (98 101).
adrenergic stimulation of the myocyte produces
increases in the phosphorylation of several proteins
associated with the increase in contractile state seen in
the perfused heart exposed to B-adrenergic agents. Phosp-
horylation of phospholamban and TNI increases with 
adrenergic stimulation (101). Additionally, a protein
associated with the slow inward calcium channel increases
in phosphorylation under similar conditions (124). Enzymes
associated with the cAMP-dependent cascade have been shown
to respond in a manner corresponding to the enzymatic
changes seen in the catecholamine challenged perfused
heart ( 143) . The presence of a B-adrenerg ic response
suggests that the stimulatory G protein (G ) mechanism(s)
is functionally intact in the isolated cell.
In addition to a functional B-adrenergic receptor
system , isolated cardiomyocytes have been shown to possess
functional muscarinic (145) and adenosinergic (58 116)
receptors. Myocytes also respond physiologically to
forskolin, insulin , glucagon and histamine (8). The
numerous functional receptors , coupled with the appropri-
ate physiological response , support the isolated cardiomy-
ocyte as a viable model for the examination of myocardial
metabo 1 ism.
since the cellular response to B-adrenergic agents
parallels the responses seen in the intact heart , it is
interesting to note that the anti-adrenergic effects of
muscarinic and adenosinergic agents are also seen in the
isolated cardiomyocyte (58 116). These anti-adrenergic
effects suggest the presence of a functional inhibitory G
protein (Gi). Furthermore , while acetylcholine produces a
decrease in cAMP levels and an increase in IP3 in myocytes
exposed to B-adrenergic agents (85), adenosine only af-
fects cAMP levels (84). These responses , again similar to
those seen in the intact organ , imply that the mechanisms
differentiating these effects are also present in the
isolated cell.
In the intact heart the anti-adrenergic effects of
adenosine and acetylcholine are associated with an attenu-
ation of adenylyl cyclase activity and cAMP-dependent
events such as protein kinase acti vi ty and protein phosp-
horylation (124). In the isolated myocyte , less is known
concerning anti-adrenergic effects involving adenosine and
acetylcholine. However , the present studies demonstrated
that adenosine produces inhibitory effects at low concen-
trations and stimulatory effects at elevated concentra-
tions. Therefore the presence of the inhibitory (Ai) and
the stimulatory (A ) adenosine receptor is suggested in
the isolated myocyte (116).
In examining myocardial metabolism , the cyclic
manner of the cardiac contraction indicates a high degree
of coordination and presupposes an efficient mechanism of
recovery to avoid energy debt. since the primary second
messenger calcium is regulated in a precise and interde-
pendent manner with cAMP , oscillations in events dependent
upon these messengers may be considered. The sarcolemma
is associated with protein-kinase related activity and
appears integral to events involved with cardiac metabo-
lism and contractility. While these intrinsic factors
provide a degree of control in myocardial function , ex-
trinsic factors , such as hormones , neurotransmitters and
metabolites appear modulatory with regard to myocardial
contractility and metabolism , with a primary means of
control effected by covalent modification of proteins by
phosphorylation.
In an effort to better understand the regulation of
myocardial metabolism and contractility, the following
studies were conducted. The cAMP levels were examined in
the perfused heart to determine what fluctuations , if any,
occurred during a single contraction cycle and whether
these fluctuations were reflected in the appropriate
biochemical sequelae. The acti vi ty and protein substrates
of several (cyclic nucleotide and calcium dependent)
protein kinases were determined at the level of the sarco-
1 emma. And the effects of the B-adrenergic agent , iso-
proterenol , as well as the anti-adrenergic agents adeno-
sine and acetylcholine , were examined with regard to cAMP
levels , cAMP-dependent protein kinase activity and the
phosphorylation of select protein substrates.
CHAPTER I I
LACK OF OSCILLATIONS IN CYCLIC AMp , cAMP-PROTEIN
KINASE AND GLYCOGEN PHOSPHORYLASE DURING THE
CARDIAC CYCLE IN THE PERFUSED RAT HEART
ABSTRACT
It is unclear whether reported fluctuations in the
level of cyclic adenosine 3' 5' -monophosphate (cAMP)
during a single cardiac cycle in ventricular muscle are
associated with distal changes in cAMP-dependent process-
es. The degree of cAMP variation and its effect , if any,
on biochemical sequelae during the cardiac cycle were
investigated by determining the level of cAMP and the
acti vi ty ratios of cAMP-dependent protein kinase and
glycogen phosphorylase in the rat ventricular myocardium.
Isolated perfused hearts contracting at 240 beats/min and
free of exogenously administered catecholamines were
freeze-clamped , utilizing an automated clamping device
capable of freezing the entire heart in less than 50
msecs. The cardiac cycle was segmented into phases uti-
lizing 3 different segmentation schemes. While no signif-
icant difference was detected between phases regardless of
the method of segmentation for cAMP , cAMP-dependent pro-
tein kinase , or glycogen phosphorylase levels , there was
an insignificant tendency for cAMP to be elevated during
early systole in one method of segmentation. These re-
suI ts suggest that the levels of cAMP and the acti vi ties
of cAMP- dependent protein kinase and glycogen phosphory-
lase do not vary significantly during a single cardiac
cycle in the mammalian myocardium.
INTRODUCTION
Previous studies in amphibian and mammalian myocar-
dium have reported oscillations in adenosine 3' , 5-cyclic
monophosphate (CAMP), guanosine 3' 5- cyclic monophosphate
(CGMP), and the activity of cAMP-dependent protein kinase
and glycogen phosphorylase that were thought to be associ-
ated with the contractile cycle (10 134 140). However , in
several of these reports the presence of catecholamines
appeared either to enhance or be required for the observed
oscillations (10 141). certain events such as the
changes observed in calcium concentration and resultant
interactions with troponin , as well as conformational
changes in the relationship between actin and myosin over
the course of a single cardiac cycle have been well de-
scribed (34 67, 70). Changes in ATP and creatine phosphate
levels , utilizing gated nuclear magnetic resonance spec-
troscopy (8), and biochemical techniques (22) suggest that
the levels of these compounds are highest during diastole
and lowest during systole. The levels of cAMP and the
acti vi ty of cAMP-dependent protein kinase and glycogen
phosphorylase have been reported to be maximal during
systole and minimal during diastole (lO , 78 134 141) . Con-
versely, the levels of cGMP have been reported to be
minimal during systole and maximum during diastole (144).
While it has been implied that these observed changes may
be inter-related , little has been offered to describe
these events with relation to the cardiac cycle in a
manner that demonstrates a cause and effect regarding the
cycle and its metabolic processes and requirements. For
example , the modest reported increase in cAMP during the
first half of systole (10 141 144) has not yet been directly
correlated with other events associated with myocardial
metabolism known to be cAMP-dependent in the mammalian
heart contracting at normal frequency and free of catecho-
lamine stimulation.
In an attempt to relate these observed fluctuations
in cAMP levels to the metabolism of the mammalian myocar-
dium , a device capable of rapidly freeze-clamping the
isolated perfused rat heart was used to examine the fluc-
tuations in cAMP levels during the contraction cycle in
the absence of exogenous catecholamine administration.
addition , the importance of these fluctuations in terms of
influencing distal biochemical sequelae were assessed by
determining the acti vi ty ratios of cyclic AMP-dependent
protein kinase and glycogen phosphorylase.
METHODS
Rats used in this study were maintained and used in
accordance with recommendations in the Guide for the Care
and Use of Laborator Animals , prepared by the Institute
of Laboratory Animal Resources , National Research Council
s. Department of Health and Human Services , National
Institutes of Health Publication No. 85-23 , rev. 1985 and
the Guidelines of the Animal Care Advisory Committee of
the university of Massachusetts Medical School.
Heart Perfusion. Isolated rat hearts were perfused ac-
cording to a method described previously (22). Briefly,
male Sprague-Dawley rats (300-350 g) were anesthetized and
heparinized (ip with a pentabarbitol: 40mg/kg and heparin:
500 units. After approximately 20 minutes hearts were
excised , briefly rinsed in ice-chilled physiological
saline (PS) and immediately perfused at 8 ml/min with
nonrecirculated PS at 37 C via an aortic cannula. The PS
contained in ro amounts: 119. 4 NaCl , 4. 7 KCl , 1. 2 Mgs0
5 CaC12' 10 glucose, 25 NaHC03 and 1. 2 KH The pH
was maintained at 7. 4 by gassing the PS with 95% 0 - 5%
Hearts were paced with a Grass SD9 stimulator 
msec duration and 10% above threshold) at 4 Hz using
platinum electrodes attached to the right atrium. Left
ventricular pressure was monitored with a saline-filled
latex balloon-tipped canula inserted into the left ventri-
cleo Perfusion was continued for 15 minutes to allow each
heart to equilibrate. Hearts that did not develop a
maximum systolic pressure of 80 mm Hg at the end of the
equilibration period were not used. The hearts had a rate
of left ventricle pressure development that averaged 4230
% 96 mm Hg/sec , and increased to 7200 mm Hg/sec with a 30
sec perfusion of 10 nM isoproterenol. At various points
during the contraction cycle , hearts were rapidly frozen
utilizing an automated freeze-clamping device described in
detail by Thompson et ale (134). Briefly, this device
utilizes the .voltage signal from the pressure transducer
as an index of the left ventricular pressure development.
The variable threshold and delay parameters are preset in
the logic controller of the device , such that the release
of the spring loaded clamps is triggered at a predeter-
mined point in the cardiac cycle. Precise resolution of
the freezing point in the cycle was provided by the moni-
toring the transducer signal via a high speed chart re-
corder (Grass Model 7D polygraph) and a memory oscillo-
scope ( ektronix R5103N) to verify the exact time of
freez ing .
Tissue Pre aration. Frozen hearts were pulverized in a
chilled Waring blender containing liquid nitrogen and
stored at -80 C prior to analysis according to methods
described previously (24). All subsequent handling of the
tissue and extracts occurred at either -20 C or in an
ice/water slurry.
Tissue Extraction and Anal sis. To measure the cAMP
content of the myocardium 30-40 mg of powdered tissue was
homogenized on ice in 0. 5 ml of 10% trichloroacetic acid
(TCA) using a Duall (Kontes , size 20) ground glass homoge-
n i z er . The homogenate was centrifuged at 3 000 x g for 2
mins (OOC), and the TCA was extracted from the supernatant
4 times with water-saturated ether. After permitting the
ether to evaporate at 80 , samples were assayed for cAMP
concentration using an 125I-cAMP RIA system (Amersham).
This assay employs a cAMP-specific antibody, with the
final separation being achieved by a second antibody bound
to a polymer , thereby permitting separation of unbound
labelled tracer by centifugation. The cAMP values are
reported in pmoljmg protein of original TCA homogenate.
Protein kinase activity of the myocardium was deter-
mined by homogenizing 20-30 mg of frozen powdered tissue
in a Duall homogenizer containing 5 volumes of a solution
containing 5 ro K HP04' 1 ro ethylenediaminetetraacetic
acid , (EDTA) and 0. 5 ro methyl- isobutylxanthine (pH 6.
and centrifuging at 12, 000 x g for 20 min (OOC). The
supernatant extract was immediately assayed in the absence
and presence of 2 ro cAMP for protein kinase acti vi ty, 
described previously (20), after the method of Keely (69).
The acti vi ty of the kinase is based on the phosphorylation
of the histone (Type II-A, calf thymus) and one unit (U)
of the enzyme is defined as the amount of enzyme that
catalyses the transfer of 1 pmol of 32p from PJATP to
histone in 1 min at 30 Protein kinase activity is
expressed as the percent activation which is the ratio of
acti vi ty in the absence of cAMP to that in the presence of
cAMP (2 ro) x 100. An increase in the percent activation
ratio is assumed to reflect dissociation of the holoenzyme
into its regulatory and active catalytic subunits. The
total protein kinase acti vi ty is expressed as that enzyme
activity determined in the presence of 2 ro cAMP per mg
protein in the supernatant.
Glycogen phosphorylase acti vi ty of the myocardial
tissue was determined by homogenizing 100 mg of the frozen
powdered tissue in 50 volumes of 100 ro KF , 50 ro 3- (N-
morpholino) ethanesulphonic acid (MES), 15 ro B-mercapto-
ethanol (BME) and 5 ro EDTA (pH 6. , OOC) with a Polytron
(Brinkman , PT10 probe; setting 5 2 x 10 sec bursts).
Nori t charcoal (50 mg) was added to each sample for a 1
minute period prior to centrifugation at 8 000 x g for 10
min at OOC to remove endogenous AMP. The supernatant was
assayed for phosphorylase acti vi ty in the absence and
presence of 2 ro AMP for both the formation of glucose-1-
phosphate and glycogen. In the former , the formation of
glucose-i-phosphate was determined after the method of
Hardman (44), through the use of coupled enzyme reactions
involving phosphoglucomutase and glucose-6-phosphate
dehydrogenase. In the latter , the filter paper method of
Gilboe (41) was utilized to measure the formation of 14
labelled glycogen. One unit of phosphorylase is defined
as the amount of enzyme that either produces 1 mmol of
glucose-i-phosphate or utilizes 1 mmol of glucose per min
at 30 The results are expressed as the percent activa-
tion which is the ratio of phosphorylase activity without
AMP to phosphorylase activity with AMP (2 ro) x 100.
increase in the percent activation indicates an increase
in the conversion of phosphorylase to The tota 
acti vi ty of the phosphorylase is expressed as that enzyme
acti vi ty determined in the presence of 2 ro AMP per mg
protein in the supernatant extract. All protein contents
were determined after the method of Lowry (89).
statistical Methods. All data are expressed as means %
one standard error of the mean. statistical significance
was determined using one way independent analysis of
variance (122). A probability of less than 0. 05 was accept-
ed as indicating a significant difference.
Materials. All reagents were either of reagent or commer-
cial grade. Calf thymus type II-A histone and 1-methyl-3-
isobutylxanthine were obtained from Sigma Chemical.
Radiolabeled compounds ( 32p) ATP and 14 C-Glucose , as well
as the cAMP radioimmunoassay kit , were obtained from
Amersham Corporation. Nucleotides , glucose , glucose-
phosphate and enzymes used for the phosphorylase assay
were obtained from Boehringer-Mannheim.
RESULTS
A typical left ventricular pressure tracing obtained
from an isolated beating rat heart is illustrated by the
chart recorder tracing shown in Figure The perfused
hearts developed a mean systolic pressure of 95 mm Hg.
Given the ability to freeze clamp a beating heart into a 1
mm thick wafer in less than 50 msec , at near liquid nitro-
gen temperature , it is estimated that a given sample will
be completely reduced to OOC in less than 10 msec.
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FIGURE 1. A typical left ventricular pressure tracing of
a perfused rat heart. Chart recorder tracing of analog
pressure signal was obtained by a balloon-tipped cannula
inserted into the left ventricle. The asterisked 
(*)
pairs of horizontal and verticle bars in pressure pulse
trace #1 depict the range of sampling variabil ty for a
typical heart due to the approximately 10 msec required to
effectively freeze-clamp the organ to OOC. The arrow in
pressure pulse 3 is an example indicating the precise
point of inflection of the pressure signal representing
the moment during the contraction cycle at which the heart
was frozen.- The freezing point was verified by monitoring
the pressure signal with a memory oscilloscope. Hearts
developed an average peak systolic pressure of 95 mm Hg.
The rectangles on pressure pulse 1 of Figure 1 demonstrate
the effect upon sampling resolution of the 10 msec varia-
bili ty inherent in the freeze-clamping methodogy. with
the high degree of sensi ti vi ty provided by the electronic
control mechanisms of the apparatus , coupled with the
mannner of segmentation of the cardiac cycle , the inter-
sample variability was effectively minimized. The abrupt
change shown by the arrow in pressure pulse 3 of Figure 1
indicates the precise point at which the heart is arrested
by freeze clamping. As indicated in the Methods , this
point was confirmed with a memory oscilloscope.
The cardiac cycle was segmented into phases by 
different schemes (A-C) as illustrated on the 3 pressure
pulses of Figure since cAMP levels have been reported
to increase in the first 10-30% of systole (10 141 144), the
methods of cardiac cycle segmentation shown in the pres-
sure pulses labelled as A and B in Figure 2 were utilized
the cycle. In pressure pulse A , the phase 1A subdivision
to subdivide the contraction and relaxation components of
encompassed diastole to a boundary representing approxi-
mately 25% of peak pressure development (PPD). Phase 2A
continues from the upper boundary of phase 1A to a cut-off
point representing PPD. Phase 3A represents the period of
the cardiac cycle from PPD to diastole , a phase felt to
correspond to relaxation related events in the cycle. In
pressure tracing B of Figure 2 , the cardiac cycle was
subdivided into 4 phases , with the 2 phases in systole
representing the period from diastole to 50% PPD (phase
1B) and 51% PPD to PPD (phase 2B) and the 2 phases during
relaxation delineating the periods from PPD to a period
corresponding to a 50% reduction in pressure (phase 3B)
and a final phase (4B) occurring from the lower boundary
of phase 3a to diastole. Scheme C in Figure 2 segments
the cardiac cycle into 2 phases , diastole to PPD (phase
1C) and PPD to diastole (phase 2C).
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FIGURE 2. Cardiac cycle segmentation schemes of perfused
rat hearts. The cardiac cycle was segmented by 3 different
schemes (A, B, C, ), into 2 to 4 phases per cycle. The
limits of each phase are delineated by the triangles
adjacent to each pressure pulse and defined in Results.
Individual phases were numbered in a manner to uniquely
identify a particular phase in a given mode of cardiac
cycle segmentation (ie. , 1A = phase 1, segmentation meth-
odology A). The position of the phase label on the pres-
sure pulse tracing represents the mean time point in the
phase at which the hearts were frozen.
The myocardial levels of cAMP as well as the percent
activition of cAMP-dependent protein kinase (PKA) and
glycogen phosphorylase (plase) for the different phases of
segmentation schemes (A-C) are shown in Table 
cAMP PKA Plase (G-l-P) Plase (G)
ment(n)
(5) 4. 00 :! 1. 0 14. 4:!1. 11. 8:!3. 27. :! 2.
(5) 92:!1. 12. 3:!1. 12. 3:! 3. 20; 8 :! 2.
(5) 63:! 0. 13. 4:! 1. 12. 9 :! 3. 26. 6:! 3.
(3) 15:!1.2 15. 2:! 1. 12. :! 1. 8 26. 5 :! 5.
( 3) 58:! 0. 13. 0:!1.1 73 :! 2. 20. 0 :! 4.
(3) 49:! 0. 13. 8 :! 3. 11.5:!2. 24. 5 :! 7.
( 3) 05:! 1. 13. 6:! 1. 12. 6:! 2. 28. :! 2.
1 C (8 )
( 8)
78:!0. 14. 3 :! 0. 10. 9:!1.1 23. 5 :! 2.
77:! 0. 13. 1 :! 1. 12. 2:! 1. 26. 5 :! 3.
Table 1. The content of cAMP and the percent activation
of cAMP dependent protein kinase and glycogen phosphory-lase during various phases of the cardiac cycle. The
cAMP, cAMP dependent protein kinase (PKA) and glycogen
phosphorylase (plase) values represent the mean I 1 SE for
the number of hearts given in each phase. Cyclic AMP is
expressed in pmol/mg protein. PKA percent activation is
expressed as the ratio of activity -cAMP/+cAMP x 100.
. The percent activation of glycogen phophorylase both in
the direction of glucose-i-phosphate (plase , G-1-P) and
glycogen (plase , G) formation is expressed as the ratio of
activity -AMP/+AMP x 100. See Methods for furtherdetails.
In segmentation scheme A , cAMP levels ranged from 2. 63 to
00 pmol/mg protein (lA-3A) and did not vary significant-
ly during the cardiac cycle. The percent activation of
PKA ranged from 12. 3 to 14. 4 and did not vary significant-
ly over phases 1A to 3A. The percent acti vi tion of glyco-
gen phosphorylase , determined in the direction of
glucose-i-phosphate or glycogen formation ranged from 11.
to 12. 9 or 20. 8 to 27. , respectively, over phases 1A to
3A and did not vary significantly over the cardiac cycle.
In segmentation scheme B, cAMP levels ranged from 2. 49 to
15 pmol/mg protein (lB-4B) and did not vary significant-
ly over the cardiac cycle. PKA percent acti vi tion ranged
from 13. 0 to 15. , with no significant differences over
phases 1B to 4B. Glycogen phosphorylase percent activa-
tion as determined by the formation of glucose-i-phosphate
or glycogen ranged from 8. 7 to 12. 6 or 20. 0 to 28.
respectively . There was no significant difference between
phases for the activation of phosphorylase as determined
by the formation of either product. In segmentation
scheme C , cAMP levels ranged between 2. 77 and 3. 78 pmol/mg
protein with no significant differences between phases.
PKA percent activation ranged from 13. 1 to 14. 3 and did
not significantly vary between phases. Glycogen phospho-
rylase percent activition , in terms of glucose-i-phosphate
formation , ranged from 10. 9 to 12. 2, and from 23. 5 to 26.
in terms of the glycogen formation assay method. Nei ther
assay method demonstrated significant differences between
phases of the cardiac cycle. Total PKA activity for all
hearts ranged between 4. 2 to 5. 0 mmol phosphate/min/mg
supernatant protein and did not vary in any phase for
segmentation schemes A-C. Total glycogen phosphorylase
acti vi ty also did not vary for any phase of these segmen-
tat ion schemes and ranged between 6. 2 to 7. 8 mmol phos-
phate/min/mg supernatant protein for the formation of
glycogen.
DISCUSSION
Analysis of a single cardiac cycle in the perfused
contracting mammalian heart presents a fundamental diffi-
cuI ty. The short duration (250 msec in rat) of a single
cycle has made it extremely diff icul t to accurately iso-
late a particular point of the cycle. In the amphibian
heart the longer cycle duration (1 cycle/sec) has permit-
ted a greater segmentation of systole and diastole.
Additionally, the relative insensitivity to temperature of
amphibian myocardium has greatly facilitated experimental
manipulation. The amphibian tolerance to lower tempera-
tures (10 C), coupled with the concomitant increase in the
cardiac contraction cycle duration (2-3 sec/cycle),
presents a larger sampling window and permits a more
precise point to point resolution of the cycle. In the
mammalian myocardium previous reports have described
various metabolic changes from systole to diastole in the
perfused heart (134 141). However , in these reported stud-
ies the methods of perfusion were significantly altered
from the routine conditions employed in aortic retrograde
perfusion techniques. One modified perfusion protocol
where an oscillation in cyclic AMP was observed , involved
the use of low concentrations of isoproterenol and insulin
added to a high Ca 2+ perfusion medium delivered at an
elevated perfusion pressure to stress the heart (141).
This modified protocol could have produced an alteration
in inotropic state , which may have compromised metabolic
descr iption of the cardiac cycle. In another study where
an oscillation in phosphorylase was observed (134), the
temperature of the perfused rat myocardium was lowered to
The sinoatrial node was destroyed by crushing,
lidocaine was topically administered and Ca2+ was replaced
in the perfusion media with sr , all for the purpose of
extending the length of the cardiac cycle from its normal
duration of 250-300 msec to appromimately 1 second in
duration. In this instance , the marked variation from
standard physiological conditions to produce an elongated
contraction cycle must be considered in the interpretation
of the physiological significance of the findings. oscil-
lations of cAMP , cAMP-dependent protein kinase , and glyco-
gen phosphorylase were observed during the cardiac cycle
in an anesthetized open-chest canine preparation but were
not seen upon propanolol administration (78). These
results suggested that the oscillations were dependent on
beat-to-beat endogenous neuronal catecholamine release.
By maintaining perfusion conditions routinely used
in working heart preparations it is believed the results
presented herein are physiologically representative of the
heart in vivo , particularly when catecholamine stimulation
is absent. While no significant difference was noted in
cAMP levels between the various phases of the cardiac
cycle , higher values only tended to occur in the earlier
phases of pressure development. These findings are in
agreement with previous reports (24 78) indicating that
cAMP does not vary during the cardiac cycle in mammalian
preparations either free of catecholamine stimulation or
in the presence of propanolol , a B-adrenergic antagonist.
However , the present findings do not confirm the oscilla-
tions in cAMP reported for amphibian cardiac muscle
(10 144). This disagreement could be do to species and/ 
preparation differences. The significance of cAMP varia-
tion during the cardiac cycle was examined in light of two
distal biochemical events in the heart known to be influ-
enced by the cyclic nucleotide , such as cAMP-dependent
protein kinase and glycogen phosphorylase. Yet , no sig-
nificant differences were noted in these cAMP-dependent
events in the heart regardless of the method of cardiac
cycle segmentation employed. These observations do not
deny the possibility that cAMP may vary in a manner not
detectable by techniques employed in this study. However
variation in these distal events , known to be influenced
by cAMP modulation , most likely would have been observed
if the variation in cAMP levels were significant.
Previously reported changes in certain metabolites
such as creatine phosphate and ATP (38 144) could be impli-
cated , on a single cycle basis, to be changing as a direct
result of biochemical events during a single cycle. When
examined in view of the reaction kinetics of enzymes such
as creatine kinase, with its rate of activity being suffi-
ciently rapid to buffer any single cycle deficits in ATP
and actomyosin associated ATPase activity corresponding to
the millisecond rate of cross-bridge turnover , it can be
appreciated that certain metabolic events probably occur
in a cyclical manner during a single cardiac cycle
93). Additionally, in consideration of cellular
energetics , it has been reported that the slow transport
of NADH to the mitochondria demonstrates the limitations
of glycolysis in meeting energy demands in the heart (7),
whereas pyruvate perfused hearts have shown the importance
of high energy phosphates in beat-to-beat metabolic events
(141). It is also unlikely that a second messenger such as
cAMP could produce the multiple , sequential changes in
activities of the cascade of enzymes implicated in the
coordination of events during a single mammalian cardiac
cycle , given the current understanding of enzyme response
to hormone induced changes in cAMP levels. It has been
shown in the rat heart that cAMP response to epinephrine
occurs within 5 secs of hormone administration , and while
cAMP-dependent protein kinase activation follows a similar
time course , glycogen phosphorylase activation demon-
strates a lag of 5-15 secs (22). While such changes are
extremely rapid, events associated with the mammalian
cardiac contraction cycle would require responses on the
order of milliseconds (such as actomyosin associate AT-
Pase) rather than seconds. Even cons ider ing the reported
compartmentalization of cAMP (91 133) and protein kinase
(20) within the myocyte , the various proposed transloca-
tions required may be too slow to provide a modulatory
effect during a single cardiac cycle. Furthermore , it has
been previously reported that no change in cAMP was ob-
served between systole and diastole in isolated guinea pig
papillary muscle (29). While the concept of localized
compartments or pools of cAMP and protein kinase would
present an attractive mechanism for cardiac cycle regula-
tion , the concept has not been without drawbacks. Given
the current appreciation of ventricular myocyte ultra-
structure (7), the definitive demonstration of intracel-
lular compartments has been difficult , and while associa-
tions may be made to the cytosolic or membrane associated
fractions , little evidence is available to allow specific
localization to areas such as sarcolemma , sarcoplasmic
reticulum , mitochondria , etc. (20 52) . Tradi tionally the
role of a second messenger such as cAMP has been to pro-
duce slower , longer term responses rather than those
associated with the rapid on and off steps seen in events
such as the cyclic regulation of the ATPase associated
wi th the actomyosin complex. Consequently, oscillation in
cyclic nucleotides (CAMP) during a single cardiac cycle
would appear to represent a localized metabolic event or a
minor metabolic variant rather than a significant biochem-
ical modulator.
In summary, it was found that cAMP levels in the
myocardium remained unchanged during the cardiac cycle in
the contracting heart developing pressure in the absence
of added catecholamines. Myocardial cyclic AMP- dependent
protein kinase and glycogen phosphorylase activities also
remain constant during a single cycle.
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CHAPTER III
ENDOGENOUS PROTEIN KINASE ACTIVITIES OF CARDIAC
SARCOLEMM AS DETERMINED BY SYNTHETIC PEPTIDES
ABSTRACT
Cardiac sarcolemma (SL) display ion channel , recep-
tor and transport functions that are presumably influenced
by membrane protein phosphorylations. Since protein
kinase activity is important for protein phosphorylation
a highly purified canine SL preparation was examined for
associated protein kinase activities utilizing synthetic
peptide substrates. Cyclic AMP-dependent protein kinase
activity of the membranes was 1606 i 193 nmol 32P/min/~g
SL using KEMPTIDE as the substrate. 20' a site specific
inhibitor of cAMP-dependent protein kinase blocked this
acti vi ty. Calcium/calmodulin-dependent protein kinase
activity, determined with a specific calcium/calmodulin-
dependent protein kinase substrate , was 353 i 59 nmol
P/min/~g SL and dependent on the presence of calmodulin.
Cyclic GMP dependent protein kinase acti vi ty, measured
using an H2B heptapeptide , was 35. 7 i 6. 9 nmol 32P/min/~g
SL and only observed in the presence of exogenously added
cGMP . Calcium/phospholipid dependent protein kinase
activity, measured using a synthetic peptide analogous to
a segment of the EGF receptor , was 13. 2 i 2. 4 nmol
P/min/~g SL and EGTA sensitive. In vitro SL phosphory-
lation, performed in the absence and presence of IP20'
support the results observed with the synthetic sub-
strates. While calcium/calmodulin-dependent protein
kinase, cGMP-dependent protein kinase and calcium/phospho-
lipid-dependent protein kinase are all associated with
cardiac SL , cAMP-dependent protein kinase appears the
predominant sarcolemmal kinase.
Introduction
Protein phosphorylation reactions , particularly
those stimulated by the intracellular mediators , cAMP
cGMP and calcium are recognized as physiologic effectors
mediating the actions of various regulatory processes in
the mammalian heart. In the myocardium , protein phosphory-
lation has been associated with changes in ion channel
activity (137), alterations in myofibrillar interactions
(40), modulation of receptor sensitivity (33) and the
regulation of enzyme activity (123). Al though is evi-
dent that regulatory processes utilizing protein phospho-
rylation as an effector are most often expressed as the
integration of several signals converging upon one or more
end "points; i. e. a single channel type or a number of
different contractile proteins , the study of protein
phosphorylation has provided the ability to focus on
individual steps in an often complex series of events.
The critical role of protein kinases in phosphoryla-
tion reactions has been described from many viewpoints.
since protein phosphorylation has been shown to be a
critical component of transmembranal signaling (106), the
actions of protein kinases at the level of the cardiac
sarcolemma as well as their sarcolemmal and cytoplasmic
evoked responses have become an intense area of investiga-
tion.
Cyclic AMP-dependent protein kinase , perhaps the
most extensively examined kinase in the myocardium , has
been shown to have a variety of endogenous protein sub-
strates. The functions of this kinase in the mammalian
heart include phosphorylation of proposed sarcolemmal Ca
channel associated protein (114), and sarcoplasmic reticu-
lum associated protein , phospholambam (89), myofibrillar
regulatory proteins, troponin I and C-protein (40) and the
covalent modification of intracellular enzymes (79).
Another cyclic nucleotide-dependent protein kinase , cyclic
GMP-dependent protein kinase has been reported to phospho-
rylate phospholamban and to stimulate sarcoplasmic reticu-
lum Ca++ uptake (108). Addi tionally, two calcium-dependent
protein kinases have been examined in the myocardium.
Calcium/calmodulin-dependent protein kinase is believed to
phosphorylate a sarcolemmal protein thought to be associ-
ated with the slow inward ca2+ channel , as well as the
sarcoplasmic reticular protein , phospholambam. Both of
these actions are felt to potentiate the role of cAMP-
dependent protein kinase in the phosphorylation of these
same proteins ( 12 3) . Calcium/phospholipid-dependent pro-
tein kinase has been shown to phosphorylate in an addi ti ve
manner and in conjunction with cAMP-dependent protein
kinase and calcium/calmodulin-dependent protein kinase
(63) . Al though the function of this kinase in the myocar-
dium is uncertain , with its phosphorylation of a Ca
channel associated protein in the SL , calcium/phospholip-
id-dependent protein kinase may play an important role in
cell-surface signal regulated cardiac function (137 148).
While much has been done to describe the role of
particular SL-associated kinases , as well as their specif-
ic substrates , little has been offered to quantify the
kinase activity in a specific manner , given the fact that
a single endogenous substrate may be the target of several
kinases. Many protein kinases are thought to recognize a
si te of action by virtue of the amino acid sequence sur-
rounding the target residue (s) (37) . Synthetic peptide
substrates , with sequences designed to correspond to the
sites phosphorylated in the intact protein , have been
developed to specifically quantify a particular kinase
while minimizing or eliminating interference by other
kinases which may also be present.
In this study four such synthetic substrates were
used:
1. Kemptide , a substrate designed for specific recognition
by cAMP-dependent protein kinase (74), 2. a peptide corre-
sponding to the amino terminal residues of skeletal muscle
glycogen synthase for determining calcium/calmodulin-
dependent protein kinase acti vi ty (103), 3. a 23 residue
peptide corresponding to a cytoplasmic segment of the EGF
receptor for determining calcium/phospholipid-dependent
protein kinase activity (62) and 4. a heptapeptide analo-
gous to a segment of histone IIb for the assay of cGMP-
dependent protein kinase activity (43). with these pep-
tides we assessed the activity of various endogenous
protein kinase activities in a highly enriched canine
sarcolemmal preparation. In addition we assessed the
native acti vi ty of these kinases to phosphorylate endoge-
nous protein substrates in this SL preparation , and found
that the same protein substrate was phosphorylated by more
than one protein kinase. In fact there was a strong
correlation between the most active kinases , as determined
by synthetic substrates , and the greatest degree of phosp-
horylation of endogenous SL protein substrates.
METHODS
Dogs used in this study were maintained and used in
accordance with recommendations in the Guide for the Care
and Use of Laborator Animal , prepared by the Institute of
Laboratory Animal Resources , National Research Council
s. Department of Health and Human Services , National
Institutes of Health Publication No. 85-23 , rev. 1985 and
the Guidelines of the Animal Care Advisory Committee of
the Uni versi ty of Massachusetts Medical School.
Isolation of Canine Cardiac Sarcolemma. Highly enriched
sarcolemmal vesicles were prepared from canine left ven-
tricle after a modification of the method of Jones (68).
In brief , 150-200 g of left ventricle wall was dissected
free of fat and surface arteries and minced in a Waring
meat grinder. The minced tissue was separated into 30 g
aliquots , placed into 250 ml polycarbonate centrifuge
bottles (Sorvall) with 120 ml of a solution containing 10
ro Histidine and 0. 75 M NaCl t Solution I and homogenized
for 5 sec using a Polytron (Brinkman Instr. ) PT20 set a
half maximal speed. Following a 20 min centrifugation
(40C) at 14 000 x g in a Sorvall RC-5 centrifuge using a
GSA rotor , the supernatant was discarded , the pellet was
resuspended in 120 ml of fresh solution I and the above
homogenization was repeated. After centrifuging as de-
scribed above , the supernatant was again discarded and the
pellet was resuspended in 120 ml of a solution containing
5 ro Histidine and 10 mM NaHC03 iSolution IIJ, with the
above homogenization and centrifugation repeated. Again
the supernatant was discarded and the pellet was resus-
pended in 100 ml of solution II. Each suspension was then
homogenized for 3 , 30 sec periods. Following a 20 min
centrifugation at 14 000 x g, the pellets were discarded
while the supernatants were pooled and aliquoted into 50
ml polyethylene tubes (Sorvall) and centrifuged for 30 min
at 44 000 x g in an SS-34 rotor. The pellets were sus-
pended in 30 ml chilled deionized water and then combined
with an equal volume of a solution containing 2 M sucrose
300 mM NaCl , 50 ro tetrasodium pyrophosphate and 100 ro
Tris (pH 7. 1). Ten ml aliquots were placed in Ti 70
ultracentrifuge tubes and gently covered with 7 ml of a
solution containing 0. 6 M sucrose , 300 ro NaCl , 50 ro
tetrasodium pyrophosphate and 100 ro Tris (pH7 . 1) . The
remainder of the tube (approximately 7 ml) was carefully
topped off with a solution containing 0. 25 M sucrose and
10 ro Histidine. The sealed tubes were centrifuged in a
Beckman L8-70M ultracentrifuge at 360 000 x g (4oC) for 54
min using a Ti 70 rotor. After centrifugation , the cloudy
band (containing the most tightly sealed vesicles) appear-
ing at the 0. 25/0. 6 M sucrose interface was collected by
syringe , mixed with an equal volume of chilled deionized
water and centrifuged at 150 000 x g in a Ti 70 rotor for
30 min (2oC). The pellets were resuspended in the buffer
containing 0. 25 M sucrose and 10 ro histidine and stored
in 0. 25 ml aliquots at -70oC for later use. The protein
yield was approximately 15-20 mg sarcolemmal protein per
200 g ventricle as determined by Lowry protein assay (17)
wi th bovine serum albumin as a standard.
All dissection and tissue processing were performed
in a temperature controlled room (4 C) with all solutions
kept on ice and all tissue homogenization performed in an
ice/water slurry.
Assay of Protein Kinases utilizing kinase specific
synthetic substrates , in the presence of(t_ PJATP (0.
~C/ ~l), the phosphorylated substrates were isolated using
a phosphocellulose/phosphoric acid assay system (113).
For each assay, sarcolemmal samples were washed twice
(50 000 x g, 15 min) and resuspended in 10 ro histidine to
a final protein concentration of 1 mg/ml. All reactions
were carried out in the presence of 25 ro HEPES (pH 7. 2) ,
10 ro MgC12' 1 mM ATP , and 1 mg /ml bovine serum albumin.
All assays , with the exception of a portion of the cAMP-
dependent protein kinase (+cAMP), were conducted in the
presence of 1 ~g/ml IP20' a protein kinase A inhibitor
(17). All assays , with the exception of the
calcium/phospholipid-dependent protein kinase (+Ca
portion) and calcium/calmodulin-dependent protein kinase
(+ca2+ portion), were conducted in the presence of 5 ro
EGTA. Trifluoperizine , an inhibitor of calcium/calmodu-
lin-dependent protein kinase activity (27), was used in
the assay for control activity of calcium/calmodulin-
dependent protein kinase as well as for both steps (iCa
of the assay for calcium/phospholipid-dependent protein
kinase.
In general , a 25 ~l aliquot (1 ~g/ ~l SL protein) of
sarcolemma was added to a reaction vessel containing
either the substrate peptide (100 ~M) and the necessary
cofactors or the peptide and agents or conditions to
inhibit phosphorylation , as follows. Cyclic AMP-dependent
protein kinase was assayed using Kemptide (1 ~g/~l) in
the presence and absence of 5 ~M cAMP (12) and 1 ~g/~l
20 (17). 2+ /phospholipid dependent-protein kinase
was assayed using a synthetic peptide (62) modeled from
the epidermal growth factor receptor in the absence and
presence of 100 ~M CaC1 2+ /calmodulin dependent-
protein kinase was assayed using a synthetic peptide
substrate (103) modeled from a segment of skeletal muscle
glycogen synthase in the absence and presence of 100 ~M
CaC1 clic GMP-de endent rotein kinase PKG was
assayed using a synthetic substrate (43) modeled from a
segment of histone IIB (calf thymus).
For each kinase assay, following a 3 min incubation
(30 C), a 50 ~l aliquot was removed from the reaction
vessel , spotted on a phosphocellulose disc (Whatman P-81)
and immediately dropped into a circulating bath containing
chilled 75 ro phosphoric acid (10-15 ml/disc) for 10
minutes. In some cases the incubation periods were varied
to determine the linearity of the reactions with time.
After 2 changes of the acid wash , and a final 5 min wash
in 50% ethanol the discs were dried and the radioactivity
was determined by liquid scintillation spectroscopy
(Packard Tri-Carb 4530 , Ecoscint diluent).
In Vitro Endoqenous Phosphorylation of Sarcolemmal Vesi-
cles Washed vesicles , reconstituted as described for the
kinase assays , were freeze-thawed in an acetone/dry ice
mixture 15 times to ensure exposure of the cytoplasmic
face prior to phosphorylation. An aliquot containing 100
~g SL protein was incubated in a 30 C water bath under
condi tions identical to those listed for the assay of the
various protein kinases with the following exceptions.
Synthetic peptides were not used in the reaction mix.
Reactions were terminated with the addition of chilled
trichloroacetic acid , to a final concentration of 5%, and
placed on ice. The trichloroacetic acid precipitation
step was used to separate the 32p bound to the substrate
proteins from the unbound (y_ pJATP. Samples were cen-
trifuged for 30 min (3 500 x g, 4oC) in an HS-4 (Sorvall)
rotor with the precipitates reconstituted in an electro-
phoresis buffer to yield a solution containing 1 mg/ml
protein 10% glycerol, 2% SDS, 0. 6% Tris , 5% B-mercapto-
ethanol and 0. 01% bromophenol blue and placed in a 950
water bath for 60 sec.
Gel Electrophoresis and Autoradioqraphy Proteins were
separated using a discontinuous SDS/PAGE system with a 12%
polyacrylamide (2. 8% cross-linker) separating gel and a 5%
stacking gel after a modification of the method of Laemmli
(82) . Approximately 65 ~g of the phosphorylated sarcolem-
mal protein was added to each gel lane and after a 20 min
period at 20 mA (constant current) the current was in-
creased to 35 ID and the gel was run until the tracking
dye flowed from the bottom of gel (3. 5-4 hours). Gels
were fixed and stained in a 25% methanol/10% acetic acid
solution containing 0. 5% Coomassie Blue (G250), destained
in a 5% glycerol/5% acetic acid solution and vacuum dried
onto sheets of Whatman #3 filter paper or dialysis mem-
brane (BioRad). The degree of protein phosphorylation
p incorporation) was determined using autoradiography
(Kodak , XAR-5 film, Dupont , Lightning plus enhancing
screen) . Exposure periods of 2-4 days were utilized to
optimize for film sensitivity. Both stained proteins and
autoradiographic images were quantified using a computer-
ized video densitometer.
Quantification of 32p incorporation into endoqenous sub-
strates. Endogenous protein substrates were quantified on
SDS/polyacrylamide gels prior to drying on filter paper or
dried on transparent dialysis membrane prior to densitome-
try. Bovine serum albumin and glycogen phosphorylase
(rabbit skeletal muscle) were utilized as standards. The
amount of 32p incorporated into each protein substrate was
determined by comparison to standards containing known
amounts of 32p placed in each film cassette along with the
gel.
PJATP was purchased from Amersham Corpo-Materials.
ration. Kemptide , trifluoperizine , EGTA and calmodulin
were purchased from Sigma Corporation. ATP , cAMP and cGMP
were obtained from Boehringer-Mannheim Corporation. X-ray
film and B-mercaptoethanol were obtained from Eastman-
Kodak. All electrophoresis reagents were obtained from
National Diagnostics Corporation. All other chemicals
were of reagent grade or better and were obtained from
commercial suppliers. The synthetic peptide substrates
for the assay of calcium/phospholipid-dependent protein
kinase , cGMP-dependent protein kinase and calcium/calmodu-
lin-dependent protein kinase were kindly provided by
Dr. L. G. Heasley, Dept. of Biochemistry, National Jewish
Center for Immunology and Respiratory Medicine , Denver
Colorado.
RESULTS
ACTIVITY OF ENDOGENOUS CARDIAC SARCOLEMML PROTEIN KI-
NASES. The time course for 32p incorporation (phosphory-
lation) into the various synthetic peptides was examined
to determine an optimal period of incubation. Peptides
are incubated for varying time periods in the presence of
25 ~g sarcolemmal protein (Figure 3), under the conditions
descr ibed in Methods.
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Figure 3. Time course of 32p incorporation into kinase
specific synthetic peptide substrates. Freeze-thawed
canine sarcolemmal microvesicles (25 ~g) were incubated
for the times indicated with synthetic substrates (100 ~M)
as described in Methods. Counts per minute (cpm) /~g
sarcolemmal protein were determined by liquid scintilla-
tion spectroscopy, with PKA and PKCM values expressed by
the scale on the left ordinate and PKG and PKC values
expressed by the scale on the right ordinate. Refer 
the legend of Table I for kinase abbreviations. All
values are those determined after subtraction of basallevels of kinase acti vi ty.
All peptides were used at a final concentration of 100 ~M
a value previously reported as optimal (39 99).
wi th the exception of the +cAMP portion of the cAMP-de-
pendent protein kinase assay, the protein kinase inhibitor
protein IP20 was used in all assay systems to eliminate
interference due to endogenous cAMP-dependent protein
kinase acti vi ty. When examined with regard to counts per
minute (over control) per ~g of sarcolemmal protein , all
the measured kinases displayed a positive slope linearity
up to 8 minutes into the incubation period. This indicat-
ed that the assay system , particularly over the 3-5 min
time period used , is not substrate limited with regard to
either the synthetic substrate or PJATP. While no
difference in enzyme activity was seen in the freshly
thawed versus the freeze thawed vesicles , for the sake of
continuity, only freeze thawed vesicles were utilized in
all phases of the study.
The endogenous sarcolemmal protein kinase activities
(Table II) in the enriched vesicular preparation, were
determined using the various kinase specific synthetic
substrates (29 99), under conditions as outlined in
Methods. These activities are thought to reflect protein
kinase related events associated with the sarcolemma. All
assays (except as noted) were performed with the cAMP-
dependent protein kinase inhibitor protein IP20 present at
1 ~g/ml to eliminate any endogenous cAMP-dependent protein
kinase activity.
Cyclic AMP-dependent protein kinase: The activity
of protein kinase A , assayed using the synthetic peptide
Kemptide , was 1606 nmol 32 P/min/~g SL , the highest activi-
ty in the preparation. Even with an excess (lOX) of
cAMP-dependent protein kinase inhibitor protein (IP20)
present (17) in the assay system there was still an acti 
ity of approximately 0. 090 nmol 32P/min/ g SL present
suggesting either a slight inefficiency in the inhibitory
capacity of IP20' or perhaps the presence of a small
amount of non cAMP-dependent phosphorylation of the Kemp-
tide.
Table II: Endogenous sarcolemmal kinase activities
Kinase Substrate Acti vi t
PKA Kemptide 1606 193
PKCM SMGS 353
PKC EGF Receptor 13.
PKG H2B Heptapept. 35.
Sarcolemmal vesicles were isolated from canine
ventricle and incubated with the listed synthetic sub-
strates as described in Methods. PKA: cAMP-dependent
protein kinase , PKCM: Ca 2+ /calmodulin-dependent protein
kinase , PKC: Ca 2+ /phospholipid-dependent protein kinase
PKG: cGMP-dependent protein kinase , SMGS: skeletal muscle
glycogen synthase, EGF: epidermal growth factor , H2B:
histone 2B heptapeptide. Values are the means I SE for
4-6 different sarcolemmal preparations. * nmo1 /min/ 
sarcolemmal protein.
Calcium/calmodulin-dependent protein kinase: The
activity of calcium/calmodulin-dependent protein kinase
was assayed using a synthetic peptide modeled after the
site of phosphorylation of myosin light chain (103). The
activity of 353 nmol 32P/min/~g SL was completely abol-
ished by trifluoperizine at a concentration of 1. 0 ~M.
Calcium/phospholipid-dependent protein kinase: The
acti vi ty of protein kinase C was assayed using a synthetic
peptide modeled to the sequence of the EGF receptor , an
endogenous substrate for calcium/phospholipid-dependent
protein kinase (62). This activity was 13. 2 nmol
P/min/~g SL and was completely eliminated with 10 ro
EGTA. When the phorbol ester 12-o-tetradecanoylphorbol 
acetate was used at a concentration 1. 0 ~M , the
calcium/phospholipid-dependent protein kinase activity was
seen to increase to approximately 50 nmol 32P/min/~g SL
(data not shown). However, 12-o-tetradecanoylphorbol 
acetate stimulated activity may not reflect normal physio-
logical conditions (56 148) and consequently was not used
in the method of assay.
clic GMP-de endent rotein kinase: The activity
of CGMP-dependent protein kinase was assayed with a syn-
thetic peptide (43) corresponding to the site phosphory-
lated by this enzyme on the HIIb histone (calf thymus).
The activity level of 35. 7 nmol 32P/min/~g SL was unde-
tectable without the addition of cGMP (100 ~M).
ENDOGENOUS SARCOLEMMAL SUBSTRATE PHOSPHORYLATION. The
native activity of 4 protein kinases with respect to
endogenous protein substrates , was determined in the
freeze-thawed membranes from canine cardiac muscle , pre-
pared as descr ibed in Methods. Protein substrate phospho-
rylations , as determined by the 32p incorporation into
several protein substrates (Figure 4), were examined under
control and activating conditions (as detailed in Methods)
for cAMP-dependent protein kinase , calcium/ calmodulin-
dependent protein kinase , calcium/phospholipid-dependent
protein kinase and cGMP-dependent protein kinase.
Three distinct protein bands , with approximate
molecular weights of 15 kD , 28 kD and 90 kD (Figure 4
arrows a , b , c; d , e; and f
, g, 
respectively), were phosphory-
lated by endogenous kinase activity. The distinct phosp-
horylations of the 3 proteins (Figure 4 , lane 8), seen
when reaction conditions are optimized for cAMP-dependent
protein kinase , are still evident when the reaction condi-
tions are employed to inhibit cAMP-dependent protein
kinase and favor other endogenous kinases. Calcium/cal-
modulin-dependent protein kinase (Figure 4 , lane 4) phosp-
horylates these proteins , although to a lesser extent than
that seen with cAMP-dependent protein kinase.
Calcium/phospholipid-dependent protein kinase (Figure 4
lane 6) demonstrated a slight phosphorylation of the 15 kD
band. No detectable phosphorylation of sarcolemmal sub-
trate (s) was observed when endogenous cGMP-dependent
protein kinase acti vi ty was examined (Figure 4 , lane 2).
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Figure 4. A representative autoradiogram of 12%
SDS/polyacrylamide gel of sarcolemmal proteins. canine
sarcolemmal vesicles were prepared and incubated as de-
scribed in Methods. Each lane was loaded with 65 ~g
sarcolemmal protein. Apparent molecular weight in kilo-
Daltons (kD) is indicated in the left margin. Lanes 1 , 3
5 and 7 are control Lanes 2 , 4 , 6 , 8 are PKG , PKCM , PKC
and PKA , respectively. a , b , c; d , e; and f
, g 
represent the
endogenous protein substrates with apparent molecular
weights of 15kD , 28kD and 90kD , respectively. See legend
of Table I for kinase abbreviations. Arrows along right
margin (from bottom to top) indicate apparent molecular
weights of 15kD, 28kD and 90kD.
The quantification of 32p incorporation by the
endogenous protein substrates seen in Figure 4 was per-
formed on 5 different SL preparations with the following
results : cAMP-dependent protein kinase: Cycl ic AMP-
dependent protein kinase is the most active of the endoge-
nous kinases quantified in the sarcolemmal preparation
with the ability to transfer 2. 7 and 29. 4 nmol 32P/min/
SL protein to the 15 kD and 28 kD protein substrates
respectively, and 10. 3 pmol 3 2 /min/ ~g transferred to the
90 kD substrate. 
2+ /calmodulin-dependent protein kinase:
Calcium/calmodulin-dependent protein kinase transferred
, 17. 1 and 7. 4 pmol 32P/min/~g to the 15 kD , 28 kD and
90 kD protein substrates , respectively. 2+ /phospholip-
id-dependent protein kinase: Calc i um/phosphol ip id -depend-
ent protein kinase phosphorylated the 15 kD protein at the
rate of 0. 16 nmol 32P/min/~g. Cyclic GMP-dependent pro-
tein kinase: No endogenous substrate phosphorylation was
detectable due to cGMP-dependent protein kinase acti vi ty
using the method employed.
DISCUSSION
This study was undertaken to examine the endogenous
protein kinase activity at the level of the sarcolemma
wi th two basic methods of assessment employed. utiliz ing
kinase specific synthetic peptides , the level of native
acti vi ty was determined for cAMP-dependent protein kinase
2+ /calmodulin-dependent protein kinase , Ca 2+ /phospholip-
id-dependent protein kinase and cGMP-dependent protein
kinase in a commonly used , highly purified , canine cardiac
sarcolemmal preparation (68). These values in nmol
P/min/~g SL were 1606 , 353 , 13. 2 and , 35. , respective-
Additionally, using the same sarcolemmal preparation
the manner in which 3 endogenous protein substrates were
phosphorylated by these endogenous kinases , was deter-
mined.
The synthetic substrates offer several distinct
advantages over other methods of measuring kinase activi-
ty. Each substrate utilized has been shown to be extreme-
ly specific for a given kinase and has been shown to
exhibit Km and Vmax values similar to native substrates
(43, 62, 79, 103) .
The specificity of the synthetic substrate is most
advantageous when compared to the methods of assaying
protein kinase activity using one of the available hi-
stones (I, lIb , III etc. ) as a substrate. While the
affinity of a given enzyme for a histone substrate may be
sufficient to provide an adequate signal , the lack of
specificity of a particular histone for a given enzyme
coupled with the possible lack of purity of the histone
limits the confidence one may utilize in excluding other
kinases as a source of measured enzyme acti vi ty. Further-
more , the synthetic substrates utilized exhibit a linear
response (Fig. 1) over time , thereby permitting relatively
short periods of incubation , as well as providing assur-
ance that neither the synthetic substrate nor the ATP
present in the reaction is a limiting factor in measuring
the acti vi ty .of particular kinase. Additionally, the
precise control of the reaction conditions and the use of
the cAMP-dependent protein kinase inhibitor protein IP20'
with the synthetic peptides , maximizes the ability to
specifically quantify a particular kinase activity, while
minimizing cAMP-dependent protein kinase as a compromising
signal source in the measurement of non cAMP-dependent
protein kinases (37).
The endogenous protein kinase acti vi ties associated
with the sarcolemma , measured using the synthetic sub-
strates, are somewhat different than values previously
reported ( 81) . These differences may in part be due to
the normalization of the kinase activity to the amount of
sarcolemmal protein present compared to other reports that
normalize the activity to the total amount of protein or
tissue utilized as starting material. When the measure-
ments obtained in this study were adjusted for total
starting material (tissue weight) used , the values were
similar to other reported values (81), and discrepancies
could be explained by differences in preparation and
purification techniques employed.
The endogenous protein substrates phosphorylated by
the various kinases (Fig 2) appear to be similar to pro-
teins shown to be phosphorylated in the heart by several
previous reports (63 107 137 143). In comparing the
kinase activities determined with the synthetic peptides
to the phosphorylation of the endogenous substrates , there
is a strong correlation between the most active kinase
when measured with a synthetic peptide , to the most active
kinase with regard to the phosphorylation of endogenous
protein substrates. An exception to this correlation was
cGMP-dependent protein kinase. While showing a sarcolem-
mal level of activity equal of 35. 7 nmol 32P/min/~g,
cGMP-dependent protein kinase was not found to detectably
phosphorylate any endogenous protein substrate in the
preparation. This discrepancy is again , most likely due
to the manner in which the sarcolemma was isolated. It is
possible that the enzyme substrate was lost during isola-
tion , that the enzyme properties were altered or that the
substrate is not associated with the sarcolemma. Al terna-
ti vely, phosphorylation of endogenous substrates could be
masked by simultaneous operation of a phosphatase , al-
though conditions employed would presumably minimize this
effect. It is of interest that there is little evidence
of endogenous substrates for this enzyme in the myocardium
despite evidence for PKG activity in vitro (61).
Although calcium/phospholipid-dependent protein
kinase has been shown to phosphorylate several cardiac
sarcolemmal proteins , these reports were the result of
exogenously added kinase (63 81). When coupled to the
aforementioned differences in sarcolemmal preparations and
potential species variation , the ability to describe
confidently an event of physiological significance may be
comprised by the experimental manipulations. Also , the
sarcolemmal preparation used in this study is felt to
provide all the necessary lipid cofactors in the vesicle
itself . Consequently the addition of exogenous lipids , as
used in other studies (106), was unnecessary, if not
inappropriate.
The identity of the endogenous proteins phosphory-
lated in the preparation in uncertain. It is believed
that the 28 kD substrate is most likely the protein phos-
pholambam , given its molecular weight and its tendency to
dissociate into 6 kD and 12 kD subunits when boiled for
longer periods (3-5 min) in a solution containing 2% SDS
(106). Although this protein is thought to be a membrane
component of the sarcoplasmic reticulum , it is probably
present as a contaminant of this sarcolemmal preparation
(71) . While this preparation is believed to be extremely
pure , it must be noted that angiotensin converting enzyme
acti vi ty in these SL was seen to be greatly enhanced over
values determined in homogenized myocardial samples
(116 135) . since angiotensin converting enzyme activity
in the heart resides primarily in the vascular endotheli-
, it is assumed that this sarcolemmal preparation con-
tains considerable contamination from components of the
heart other than the myocyte (71).
Although previous studies have found that an 88-92
kD protein is phosphorylated by calcium/phospholipid-
dependent protein kinase in sarcolemmal preparations
(63 148), such phosphorylation was only observed in the
presence of cAMP-dependent protein kinase or
calcium/ calmodulin-dependent protein kinase. The inabili-
ty to detect this phosphorylation in the present investi-
gation could again be the result of either exogenously
added calcium/phospholipid-dependent protein kinase used
in earlier studies or differences in the preparation of
the sarcolemma.
The 15 kD protein that was phosphorylated by cAMP-
dependent protein kinase , calcium/calmodulin-dependent
protein kinase and calcium/phospholipid-dependent protein
kinase appears similar to the sarcolemmal cytoplasmic face
protein described by Presti et ale (106 107), in that it was
only seen in membranes having been freeze thawed prior to
phosphorylation to expose the cytoplasmic face of the
sarcolemma. This protein is distinguished from phospho-
lambam by virtue of the insensitivity of the protein to
boiling in SDS prior to electrophoresis. While phospho-
lambam can be broken down to its smaller molecular weight
subuni ts, the 15 kD protein is stable and remains un-
changed under similar treatment. Whether associated with
a channel , receptor , transporter or some other component
of the sarcolemma the function of this 15 kD protein
remains to be established. However it presumably plays
some role in protein phosphorylation mediated events at
the level of the sarcolemma (6 106 107).
In conclusion , cAMP-dependent protein kinase , calci-
um/calmodulin-dependent protein kinase , calcium/phospho-
lipid-dependent protein kinase and cGMP-dependent protein
kinase acti vi ties appear to be associated with a highly
enriched canine cardiac sarcolemma preparation , with
active. Sarcolemmal phosphorylations by endogenous pro-
cAMP-dependent protein kinase clearly being the most
tein kinases support the results obtained by assay of the
kinases using specific synthetic substrates , thereby
demonstrating the value of these substrates as a method of
quantifying membrane kinase activity. Additionally,
endogenous sarcolemmal phosphorylation clearly demon-
strates that a given sarcolemmal substrate may well be
phosphorylated by several different kinases associated
with the cardiac sarcolemma.
Preliminary report of this work has been presented
(FED. PROC. 46: 5492 , 1987)
This work was supported by
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CHAPTER IV
ADENOSINE AND ACETYLCHOLINE REDUCE ISOPROTERENOL-INDUCED
PROTEIN PHOSPHORYLATION OF RAT MYOCYTES
ABSTRACT
Adenosinergic and muscarinic agents have been shown
to attenuate the catecholamine- induced augmentation of
both protein phosphorylation and contractile state in
perfused hearts. The attenuation by phenylisopropyladeno-
sine (PIA) and carbamylcholine chloride (CARB) of the
isoproterenol- (ISO) induced incorporation of 32p into
protein substrates was examined in isolated rat ventricu-
lar myocytes. p labeled myocytes exposed to ISO
(0. 1 ~M , 30 sec) demonstrated up to an 8-fold increase of
p incorporation into 3 protein substrates (155, 6 kD).
When myocytes were pre-incubated with either PIA or CARB
for 60 sec prior to the ISO exposure , the ISO induced 32
incorporation (in the 31 kD and the 155 kD substrates) was
attenuated. This reduction averaged 37% and 25%, respec-
tively by 1 ~M PIA and averaged only 23% and 11% for these
substrates after pretreatment with 10 ~M PIA. One ~M CARB
produced a 24% and 17% reduction in these same substrates
while 10 ~M CARB produced a 44% and 50% reduction. The
effects of ISO were prevented by 10 ~M propanolol. The
inhibitory effects of PIA were antagonized by theophyl-
line , sulfophenyltheophylline and DPCPX, whereas atropine
antagonized the inhibitory effects of CARB. Addi tionally,
while PIA and CARB reduced the ISO-induced increase in
cAMP-dependent protein kinase (PKA) activity by 48% and
41% , respectively, only CARB affected the ISO-elicited
increase in cAMP levels , attenuating this response by 58%.
The results indicate that PIA was less effective in atten-
uating ISo- induced 32p incorporation at higher concentra-
tions than at lower concentrations. Moreover this com-
pound was less potent than CARB at attenuating the effects
of ISO. It is conceivable that this difference could be
related to activation of stimulatory adenosine receptors
2) and/or a greater density of muscarinic receptors
including multiple muscarinic pathways.
INTRODUCTION
The increase in contractile state of the myocardium
produced by B-adrenergic agonists is thought to be due to
a receptor coupled mechanism. This receptor system in the
heart is believed to mediate its physiological actions via
a second messenger system that ultimately results in an
enhancement in specific protein phosphorylations (123).
Adenosinergic and muscarinic agonists are known to attenu-
ate B-adrenergic induced responses in the heart
(22 88) .
In the myocardium , the agonist , isoproterenol
causes an increase in the intracellular level of cyclic
adenosine 3' 5' - monophosphate (cAMP) by transmembrane
coupling of the receptor via a GTP binding protein , Gs' to
the enzyme adenylyl cyclase (115). This increase in cAMP
in turn activates cAMP-dependent protein kinase (PKA), an
enzyme known to effect the phosphorylation state of cyto-
plasmic and membrane associated proteins (25).
In the mammalian heart isoproterenol elicits an
increase in contractile state that is associated with an
enhanced phosphorylation of several proteins , as evidenced
by protein substrate 32p incorporation (25 109). PKA is
thought to catalyze the phosphorylation of a cardiac
calcium channel associated protein , phospholamban (33 87),
troponin I and the thick filament protein known as C
protein (40). Additionally, it has been shown that ade-
nosinergic and muscarinic agonists attenuate the catecho-
lamine-induced increase in contractile state of perfused
hearts (36 47, 87) . concomi tant with this attenuation is a
reduction in myocardial cAMP levels , a decrease in the
level of protein phosphorylation of several substrates and
reduced activation of PKA and glycogen phosphorylase
(23 27).
The antiadrenergic actions of both adenosinergic and
cholinergic agonists in the heart are known to occur by
means of cell-membrane receptors designated as adenosiner-
gic (Ai) and cholinergic (M2)' respectively (58 90). Both
of these receptor types are thought to evoke a portion of
their intracellular effects by means of a transmembrane
GTP binding protein which couples the receptor to adenylyl
cyclase (65). While there is evidence for the presence of
both Ai and A2 adenosine receptors in the myocardium
(116), the Ai subtype appears to be predominant (58).
Myocyte adenosine Ai and A2 receptors inhibit and stimu-
late respectively with regard to adenylyl cyclase and are
presumably located on the extracellular surface (116).
The extracellular muscarinic receptor , M2' is inhibitory
to adenylyl cyclase (90).
Investigations utilizing the perfused heart have
benefited from the ability to correlate changes in pres-
sure generation with metabolic changes , such as variations
in enzyme activities and protein phosphorylation. Howev-
, the perfused heart has numerous cell types present
which emanate from muscle , nervous , vascular and connec-
tive tissue. Dispersed primary cultured ventricular
myocytes , free of other cell types , improve the resolution
and understanding of biochemical changes seen in the
myocardium. These myocytes possess B-adrenerg ic , adenosi-
nergic and muscarinic receptors that respond to isoproter-
enol , adenosine, and acetylcholine , as well as a function-
al adenylyl cyclase (12 116).
The purpose of this investigation was to examine the
antiadrenergic effects of adenosine and acetylcholine on
adrenergic receptor-mediated protein phosphorylation
PKA activation and cAMP formation using primary cultured
rat ventricular myocytes.
METHODS
Rats used in this study were maintained and used in
accordance with recommendations in the Guide for the Care
and Use of Laboratory Animals , prepared by the Institute
of Laboratory Animal Resources , National Research Council
u. S. Department of Health and Human Services , National
Institutes of Health Publication No. 85-23 , rev. 1985 and
the Guidelines of the Animal Care Advisory Committee of
the University of Massachusetts Medical School.
MYOCYTE ISOLATION. Isolated , calcium tolerant ventricular
myocytes were obtained from male Sprague-Dawley rats
(275-350 g) by enzymatic disassociation using a combina-
tion of collagenase and hyaluronidase as previously de-
scribed (116). Isolated cells were plated on culture
dishes that were pre incubated for a minimum of 4 hours
with media M199 (25 ro N-2-hydroxyethylpiperazine-N'
-2-
ethanesulfonic acid , HEPES pH 7. 4) supplemented with 5.
heat inactivated fetal calf serum (FCS , Gibco). The final
concentration of FCS after addition of the cells to the
culture plates (approximately 10 6 cells per 60 mm dish),
was approximately 4%. Dishes were maintained from the
pre-incubation phase through completion of the experiment
in a humidified , quick recovery incubator (37oC) under
constant gassing with a 5% C0 room air mixture. Prepara-
tions that did not yield a minimum of 60-70% rod shaped
cells , as determined by microscopic inspection at final
settling, were discarded.
PROTEIN PHOSPHORYLATION. Two hours after plating, the
media and any accompanying debris were aspirated and
replaced with fresh media containing 50 Ci per ml 32p as
orthophosphate , with the myocytes at this point being
approximately 90% rod-shaped. After 90 min , the media was
replaced with fresh media of the same specific radioactiv-
ity of 32 , plus ISO , PIA , CARB , propanolol , etc. as
indicated. Where utilized , adenosine deaminase (ADA), was
introduced at 2 units/ml M199 during the 90 min period
used for 32p loading of the cells. All experimental
manipulations were carried out in the incubator to control
temperature and the gaseous environment. The experimental
periods were terminated by rapid aspiration of the media
followed by immediate flotation of the culture dish on
liquid nitrogen. Cells were maintained at -75oC until
harvested for analysis.
P' _ P1ATP SPECIFIC RADIOACTIVITY To ensure that specif-
ic radioactivity levels of ATP remained constant within
preparations PJATP specific activity levels in
several preparations were examined over the various exper-
imental manipulations utilizing a casein based assay
system (14). Briefly, the cells were homogenized in 5%
perchloric acid (PCA), the soluble extracts neutralized
and the extract ATP levels determined fluorometrically.
The neutralized extracts were then incubated in the
presence of PKA , cAMP and casein. The incorporation of
p into casein from ATP was measured by PCA pre-
cipitation of the protein on filter paper. casein
formation was linearly related to the specific radioactiv-
ity of the PJATP. The specific activity of the cell
preparations did not vary from control when treated with
ISO (1 ~M) or ISO in combination with either PIA (1 ~M) or
CARB (10 ~M).
CELL HARVESTING. In all cases , frozen cells were harvest-
ed over ice by scraping with a rubber policeman in an
ice-chilled solution (OoC) using 2 x 650 ~l washes per
dish and placed into 1. 5 ml centrifuge tubes (Eppendorf,
polypropylene , Flex-Tube) on ice. For rotein hos hor
lation and immunotransfer , cells were harvested in a
solution containing 100 ro KF and 5 ro EDTA then centr i-
The supernatant was discarded and the pellet was
reconstituted in 300 ~l of 1. 0% sodium dodecyl sulfate
(SDS) . For cAMP determinations , cells were similarly
harvested using a chilled solution of 65% ethanol , with
the resultant suspension centrifuged as mentioned above.
The supernatants were dried and reconstituted in a buffer
containing 50 mM sodium acetate (pH 6. 0) and 0. 01% thimer-
osol and stored at -20oC until assayed. The pellet was
resuspended in 1% SDS for protein determination. For cAMP
dependent protein kinase assav , cells were harvested by
the same manner as described above using a harvesting
buffer containing 50 mM 3- 3)propanesulfonic
acid (MOPS , pH 7. 2), 0. 1% Nonidet-P40 and 10 ro MgC12' and
sonicated over ice (2 x 5 sec burst) to obtain a cellular
homogenate. The resultant homogenate was assayed for PKA
acti vi ty and total myocyte protein.
CYCLIC AMP DETERMINATION. The cAMP levels in the myocyte
extracts reconstituted in the sodium acetate buffer were
determined using an 125I-cAMP RIA kit (Amersham). This
assay employs a cAMP specific rabbit antibody, with the
final separation being achieved by a second antibody
(donkey) bound to a polymer , thereby permitting separation
of the unbound labeled tracer by centrifugation. The cAMP
values are reported in pmol/mg protein of the original
ethanol pellet (total cell protein). In this laboratory,
this manner of cAMP assay routinely provides recovery
values in excess of 90% in similar cellular preparations.
values in excess of 90% in similar cellular preparations.
PROTEIN KINASE ACTIVITY. The level of cAMP-dependent
protein kinase activity was determined by measuring 32
incorporation into the synthetic peptide substrate , Kemp-
tide , in a phosphocellulose/phosphoric acid assay system
(113). The assay mixture contained 25 ro MOPS (pH 7. 2),
10 ro MgC12' 1 ro ATP and 5 ~Ci 32p as p)ATP per
reaction vessel. The reaction was started by adding 10 ~g
of myocyte protein from the sonicated homogenate. The
reaction was incubated for 5 min at 3 o , and then was
terminated by spotting a 50 ~l aliquot from the reaction
vessel on a phosphocellulose disc (Whatman P-81). The
disc was immediately placed into a chilled circulating
bath of 75 ro phosphoric acid (10-15 ml/disc). After 2
changes of the acid wash and a 5 min rinse in 50% ethanol
the discs were dried and the radioacti vi ty was determined
by liquid scintillation spectroscopy. Protein kinase is
expressed as the ratio of activity in the absence and
presence of cAMP (2 ~M). An increase in the activity
ratio is assumed to reflect enzyme dissociation of the
holoenzyme into its regulatory and active catalytic subu-
nits. Kinase values are reported as percent activation
and reflect the activity ratios (-cAMP/+cAMP) x 100.
GEL ELECTROPHORESIS AND AUTORADIOGRAPHY. The SDS solubi-
lized myocyte particulate protein was combined with elec-
trophoresis sample buffer to yield a solution containing
5 mg/ml protein , 10% glycerol , 2% SDS , 0. 6% tris(hydrox-
01% bromophenol blue. Samples were then placed in a 95
water bath for 60 seconds. Solubilized proteins were
separated using a discontinuous SDS/PAGE system with a 12%
polyacrylamide (2. 8% cross-linker) separating gel and a 5%
stacking gel , after the methods of Laemmli (82). Approxi -
mately 25 ~g of protein were loaded to each gel lane and
after a 20 min period at 20 mAmps (constant current) the
current was raised to 35 mAmps and the gel was run until
the tracking dye cleared the bottom of the gel (3. 5-4.
hours) . Gels were fixed and stained in a 0. 5% Coomassie
Blue (G2 50) solution containing 25% methanol/10% acetic
acid , destained in a 5% glycerol/5% acetic acid solution
and vacuum dried onto sheets of dialysis membrane
(BioRad) . The extent of 32p incorporation into the var-
ious protein substrates was determined using standard
autoradiography (Kodak , XAR-5 film , Dupont , Lightning Plus
enhancing screen) and was utilized as an index of the
phosphorylation state (s) of the substrates. Exposure
periods of 1-3 days were utilized to optimize the film'
range of sensitivity. Both stained proteins and autoradi-
ographic images were quantified using a computerized video
densi tometer (Imagemeasure software , IBM Personal Computer
AT) .
IMMUNOTRANSFER AND IMMUNOBLOTTING. At the conclusion of
SDS/PAG electrophoresis , gels of solubilized myocyte
particulate protein were immediately subj ected to immuno-
transfer and blotting utilizing commonly employed method-
ology (45). Briefly, the gel was soaked in a 20% methanol
transfer buffer containing 50 ro Tris , 385 ro glycine and
01% SDS , for 30 min , then transferred overnight at 1000
ID constant current (Hoefer , Model TE 50) to nitrocellu-
lose (0. 22 ~M pore , Micron Separation Inc. Strips of
nitrocellulose were blocked with 1% bovine serum albumin
(BSA) and 0. 05% polyoxyethylenesorbitan (Tween) in Tris
buffered saline (TBS , pH , 7. 5), rinsed in TBS and exposed
to primary antibody (anti-rabbit skeletal TNI from mouse)
for 60 min. Strips were then rinsed several times with
05% Tween in TBS and exposed to a secondary antibody
(anti-mouse from goat) for 60 min. After several rinses
in Tween/TBS , a color product was produced using a commer-
cially available alkaline phosphatase kit (BioRad) and the
product identification was confirmed by autoradiography.
PROTEIN DETERMINATION. Protein levels were determined
with a commercially obtained assay (Pierce) utilizing a
bicinchoninic acid-copper sulfate reaction with bovine
serum albumin (BSA) used as a standard.
All isotopes were purchased from AmershamMATERIALS.
Corporation. Kemptide , carbamyl choline chloride , propan-
0101 , forskolin, atropine , albumin , and isoproterenol were
obtained from Sigma Corporation. ATP , phenylisopropylade-
nosine (PIA) and cAMP were purchased from Boehringer-
Mannheim Corporation. 5' -N- ethylcarboxamidoadenosine
hydrate (NECA), 1 3-dipropyl-8-cyclopentylxanthine (DPCPX)
and 8-sulfophenyltheophylline were obtained from Research
Biologicals , Inc. Collagenase and hyaluronidase were
obtained from Worthington Biochemicals. Fetal calf serum
and media 199 were purchased from Gibco Corporation. All
electrophoresis reagents were purchased from National
Diagnostics Corporation. All other chemicals used were of
reagent or a superior grade and were obtained from commer-
cial suppliers. Anti-cardiac TNI was kindly provided by
Dr. K. D. Warber , Dept. of Pharmacology, University of
Miami School of Medicine , Miami , Florida. The cAMP-de-
pendent protein kinase inhibitor protein , IP20' was kindly
provided by Dr. L. G. Heasely, National Jewish Center for
Immunology and Respiratory Medicine and the Department of
Pharmacology, University of Colorado School of Medicine
Denver , Colorado.
STATISTICAL METHODS All data are expressed as means I
one standard error of the mean. statistical significance
was determined using one way independent analysis of
variance (122). A probability of less than 0. 05 was ac-
cepted as indicating a statistically significant differ-
ence.
RESULTS
ISOLATED MYOCYTE VIABILITY. The myocytes utilized are
easily obtained and physiologically viable. The cells
shown in Figure 5a (25X photograph) are collagenase/hyalu-
ronidase dispersed ventricular myocytes. These cells
exclude trypan blue , are calcium tolerant (2. 5 ro) and
reversibly contract in response to field stimulation 
msec , 50 mV).
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Figure 5. Isolated ventricular myocytes. Photograph of
adult rat primary culture (2 hr) collagenase dispersed
ventricular myocytes in medium M199 supplemented as de-
scribed in Materials and Methods. Cells have been washed
with fresh media after 90 min of incubation and are firmly
adhered to the surface of the culture dish. (a) 25X.
Cells are piated at approximately 10 /ml and demonstrate
the typical rod-shaped morphology with the dark round
spots representing damaged myocytes. (b) 300X. At
higher magnification, the rectangular shape , sharp margins
and the typical appearance of striations in the cells are
evident.
In Figure 5b , these cells at higher magnification (300X)
demonstrate the striations and abrupt cell margins charac-
teristic of the morphology of the myocyte. While dead or
dying cells may exclude trypan blue (121 140), the stria-
tions , distinct cell margins , and ability of the cells to
reversibly contract when stimulated serve as strong in-
dices of the viability of the cardiomyocytes obtained in
this preparation. Preparations of less than 60-70% viable
cells (as determined by morphology), or those that pro-
duced less than a 200% increase over control phosphoryla-
tion (as determined by 32p incorporation into a 31 kD
protein band) in response to a 30 sec exposure to O. 1 
isoproterenol were typically discarded. Cells showed less
than a 10% overall change in viability over 4 hours after
ini tial plating on culture dishes.
TIME COURSE OF PROTEIN 32p INCORPORATION. The isoproter-
enol (0. ISO) stimulated incorporation of 32p is time
dependent , with the 31kD protein substrate demonstrating a
2 fold greater change in percentage incorporation over
control than the 155kD substrate (Figure 6). The observed
response to a 5 sec ISO (0. 1 ~M) exposure may be somewhat
limited by the ability to ensure uniform mixing of the
ISO. However, there was a significant increase in percent
p incorporation in both proteins (as expressed as a
percent of control). The increase in 32p incorporation
into the 31kD and the 155kD proteins over periods of ISO
exposure of 5-120 sec ranged from 29-904% and 125-365%
respectively, over control. since the 32p incorporation
into the 31kD protein was the greater in magnitude , this
protein was selected as a reference , with the approximate
half maximal response time of 30 sec as the time period
for the maj ori ty of the experimental manipulations.
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Figure 6. Percent isoproterenol induced phosphorylation
over control. Time course of isoproterenol stimulated 32
incorporation into 31kD and 155kD protein substrates in
ventricular myocytes expressed as a percent over untreated
control. After a 90 min incubation in M199 media con-
taining 50 Ci/ml 32 as described in Methods , adherent
cells are exposed to isoproterenol for indicated lengths
of time , with the media then immediately aspirated and the
cultures flash frozen in liquid nitrogen. Values are the
, means f SE for 4-10 different preparations. Note that
ordinates are scaled differently. All values (5-120 sec)
are significantly different from the appropriate control
value and for the percent 32p incorporated by each protein
at the same time point.
PROTEIN SEPARATION AND 32p INCORPORATION WITH ISOPROTERE-
NOL IN THE ABSENCE AND PRESENCE OF PHENYLISOPROPYLADENO-
SINE OR CARBACHOL. Myocytes readily demonstrated marked
changes in 32p incorporation into various protein sub-
strates. A polyacrylamide gel and its corresponding
autoradiograph are shown in Figure 7 to demonstrate both
the stained proteins being examined , as well as the extent
change incorporation seen result
tYPiCal exper iment . The 155kD protein seen fine
band appearing near the top the gel (F igure top
arrow), while the 31kD protein appears as a broad band
(middle arrow). Both proteins show an ISO-induced (0. 1 ~M
ISO , 30 sec) increase in 32p incorporation (Figure 7B),
when lane a (control) is compared with lane The sample
in lane c on the autoradiogram demonstrates the result of
the myocytes receiving a 60 sec exposure to 1 ~M phenyli-
sopropyladenosine (PIA) immediately before being adminis-
tered the same dose of ISO as used in lane The sample
in lane d received a 60 sec pre- incubation to 10 ~M carba-
chol (CARB) prior to the ISO exposure. It is evident that
in the instances of pre-incubation with either PIA or
CARB , the incorporation of 32p observed with ISO in the
31kD and 155kD protein substrates was less than that seen
with ISO alone. It should be noted that near the bottom
of the autoradiograph (Figure 7B , bottom arrow), yet not
clearly visible on the gel , is the trace of a protein of
approximately 6kD. This protein appears to be the mono-
Figure 7. Gel electrophoresis and autoradiography. The
12% SDS/PAG gel (panel A , lanes 1-4) and resultant autora-diograph (panel B , lanes a-d) represent a typical protein
separation and film exposure of the myocytes treated as
described in the Methods. Lanes 1 and a - control. Lanes
2 and b - isoproterenol , o. 1 ~M , 30 sec. Lanes 3 and c
- Phenylisopropyladenosine , 1. 0 ~M , 60 sec , followed byisoproterenol , 0. 10 ~M , 30 sec. Lanes 4 and d - carba-
chol , 10 ~M , 60 sec , followed by isoproterenol , 0 . 10 ~M30 sec Each lane was loaded with 20 g myocyte (
loaded) protein obtained, by harvesting the treated cells
from frozen culture dishes for processing as detailed inMethods. The arrows represent the molecular weights in
ascending order of 6kD , 31kD and 155kD.
meric form of phospholamban. This identification is based on
the appearance of the protein in unboiled samples in its
pentameric form of approximately 28kD , as well as the
increase seen in 32 p incorporation into this substrate in
response to ISO. The ISO- induced 32p incorporation seen
in the 6kD protein was attenuated by PIA and CARB in a
manner similar to that observed in the 31kD and 155kD
proteins.
INHIBITION OF ISOPROTERENOL INDUCED 32p INCORPORATION BY
PIA AND CARBACHOL. Both PIA and CARB attenuated the ISO-
induced incorporation of 32p into the 31kD and 155kD
protein substrates. Samples pre incubated for 60 sec with
1 or 10 ~M or 10 ~M CARB prior to exposure for 30 sec to
1 ~M ISO showed an average inhibition of 37%, 23% and
47% respectively, for the 31kD substrate , and 25%, 11% and
35%, for the 155kD substrate , respectively (Figure 8).
The 1 ~M PIA concentration produced greater inhibition
than the 10 ~M , and 10 ~M CARB was more effective than
either dose of PIA in inhibiting the ISo-stimulated 32
incorporation seen in both the 31kD and the 155kD protein.
When the cells were plated with adenosine deaminase
present (2 units/ml M199) for the 90 min period of 32
loading of the cells prior to and during experimental
manipulations , no difference in PIA inhibition of ISO-
induced 32p incorporation was noted.
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Figure 8. The inhibition of isoproterenol stimulated 32
incorporation by phenylisopropyladenosine, and carbachol.
p loaded myocytes are exposed to either phenylisopropy-
ladenosine (PIA , 1 ~M or 10 ~M) or carbachol (Cb , 10 ~M)
for 60 sec prior to a 30 sec exposure to isoproterenol
(ISO , 0. 1 ~M). Each treatment represents the mean I SE of
8-12 experiments. All values were significantly different
when compared to the value with ISO alone. An asterisk
denotes a significant difference compared to either con-
centration of PIA with ISO.
RECEPTOR SPECIFICITY. The specif ici ty of the actions of
ISO , PIA and CARB to influence protein 32p incorporation
is demonstrated in the autoradiogram (Figure 9) by using
the antagonists, propanolol (10 ~M), 8-sulfophenyl theo-
phylline (1 ~M) or dipropylcyclopentylxanthine (DPCPX,
1 ~M), and atropine (1 ~M) , respectively.
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Figure 9. Specificity of isoproterenol, phenylisopropy-
ladenosine and carbachol. The autoradiogram of a 12%
polyacrylamide gel (SDSjPAG) loaded with 20 ~g myocyte
p loaded) protein per lane was obtained as described inMethods. The various agents were administered as follows.
Exposure to 0. 1 ~M isoproterenol was for 30 sec Prop: 60
sec prior to ISO. PIA: 60 sec prior to ISO. CARB: 60 sec
prior to ISO. Theo: 60 sec prior to PIA. ATR: 60 sec
prior to CARB. DPCPX: 60 sec prior to ISO. Lower and
upper arrowheads indicate the 31kD and 155kD substrates
respectively. Lanes 1 , 2 and , 15 are control (untreated
myocytes). Lanes 3 to 8 and 11 to 14 were ISO. Lane 4 -
Prop prior to ISO. Lanes 5 and 6 - PIA and CARB , respec-
tively, prior to ISO exposure. Lane 7 Theo , prior to
PIA , which was prior to ISO. Lane 8 - ATR , prior to CARB
which was prior to ISO. Lanes 9 and 10 - Theo and ATR,
respectively. Lane 11 - ISO. Lane 12 DPCPX, which was
prior to ISO. Lane 13 - DPCPX prior to PIA, which wasprior to ISO Lane 14 - PIA , which was prior to ISO.
Prop = propranolol (10 ~M), PIA = phenylisopropyladenosine(1. 0 ~M), CARB = carbachol (10 ~M), THEO = 8-sulfophenyl-
theophylline (1. 0 ~M), ATR = atropine sulfate (1. 0 ~M),
DPCPX = dipropylcyclopentylxanthine (0. 10 ~M).
The lanes marked as 1, 2 and 15 represent untreated
(control) myocytes. Lanes 3 and 11 represent a 30 sec
exposure to 0. 1 ~M ISO and demonstrate the 32p incorpora-
tion by the 31kD and 155kD proteins (lower and upper
arrowheads , respectively, of Figure 5). 1 ~M propanolol
blocked the ISO-induced 32p incorporation into both pro-
teins (lane 4). Lanes 7 and 8 demonstrate that the ef-
fects of PIA and CARB (lanes 5 and 6) are antagonized by
8-sulfophenyltheophylline (1 ~M) and atropine (0. 1 ~M)
respectively. sulfophenyl theophylline (1 ~M) and atro-
pine (0. 1 ~M) alone produced no effect on phosphorylation
(Lanes 9 and 10 , respectively). A concentration of 100 ~M
sulfophenyltheophylline caused a marked stimulation of
p incorporation into the 31kD and 155kD proteins (data
not shown). This stimulation was presumably the result of
a theophylline-induced inhibition of a cardiac phospho-
diesterase. Lanes 11 through 15 demonstrate that while
PIA reduces the stimulatory effect of ISO (lane 14), when
the more specific Ai antagonist DPCPX is present in con-
junction with PIA and ISO (lane 13), the inhibitory effect
of PIA is not observed. DPCPX in conjunction with ISO
(Lane 12) produces a sl ight increase in phosphorylation
when compared to ISO alone (Lane 11), however this tenden-
cy was not statistically significant.. pa
rt32P1ATP SPECIFIC ACTIVITY, cAMP and PKA The
PJATP specific radioactivity, cAMP levels and PKA
activity of the myocytes were examined (Table III) for
response to 0. 1 ~M ISO , in the absence or presence of 1 ~M
PIA or 10 ~M CARB.
TABLE III: Substrate PJATP specific radioactivity,
cAMP content , and cAMP-dependent protein kinase acti vi ty
of cardiac ventr icular myocytes.
ec. Act. cAMP PKA
Treatment
Control 1.1 12.
ISO 1. 0 32.
ISO/PIA 23. 1. 9a
ISO/CARB 4a, 22. 1. 3
Primary cultured myocytes were prepared and exposed
to various agents as described in the Methods. 32 JATP
specific radioactivity (Spec. Act. ) is expressed as
cpm/pmol. cAMP levels are expressed as pmol/mg myocyteproto Cyclic AMP-dependent protein kinase (PKA) activityis expressed as percent activation and reflects the acti 
ity ratios in the absence and presence of 2 ~M cAMP x 100
as defined in Methods. ISO , PIA and CARB were used in 0.
, 1 ~M and 10 ~M concentrations , respectively and admin-
istered as described in Figure 3. Resul ts are the mean 
SE for 4-7 different experiments. The cAMP and PKA values
were significantly different when compared to control.
-2 indicates a significant difference when compared to
ISO. indicates a significant difference when compared
to PIA with ISO.
To ensure that any variations seen in 32p incorpora-
tion were a result of the effect of a particular treatment
rather than a change in substrate specific activity, the
PJATP specific activity of myocytes treated with ISO
(0. 1 ~M), or with a combination of PIA (1 ~M) and ISO or
CARB (10 ~M) and ISO (inhibitor given 60 sec prior to ISO
exposure) . The specif ic acti vi ty remained constant with
the various treatments. The cAMP level in the myocytes
was also measured and found to be elevated 100% over
control in the presence of ISO (0. 1 ~M , 30 sec). Al though
PIA had no apparent inhibitory effect on ISO- induced
increases in cAMP formation , the stimulation of cAMP
levels seen in the presence of ISO with CARB was signifi-
cantly lower than that seen with ISO alo e and represents
a 58% inhibition of the ISO induced stimulation. The
level of PKA acti vi ty was also measured and showed an
increase in percent activation (as defined in Methods) of
170% over control values in the presence of ISO. In the
PIA and CARB pretreated cells , the percent activation was
reduced 46% and 51% respectively, relative to the PKA
activity seen with ISO alone. Addi tionally, when PKA
acti vi ty in the myocytes was measured in the presence of a
specif ic cAMP-dependent protein kinase inhibitor (17) at a
concentration of 25 ~g/ml per assay tube , the activity
induced by ISO was reduced to control levels (data not
shown) .
ISOPROTERENOL TIME COURSE SENSITIVITY TO PIA AND CARBA-
CHOL The effect of 1 M PIA and 10 ~M CARB on O. 1 
ISO-induced 32p incorporation into 31kD and 155kD protein
substrates varies according to the time of ISO exposure.
The sensi ti vi ty of O. 1 ~M ISO (15-120 sec ISO exposure)
stimulated 32p incorporation to the effects of a 60 sec
preexposure to either PIA (1 ~M) or CARB (10 ~M) is shown
in Figures lOA and lOB. The inhibitory effects of CARB on
the incorporation of 32p into the 31kD and 155kD proteins
(an inhibition of 70% and 46%, respectively) appear earli-
er (15 sec , lOA and lOB) than do those of PIA. At the 30
sec time point , the inhibitory effects of PIA are seen
with inhibition of 37% and 25% seen for the 31kD and 155kD
proteins , respectively. CARB produced inhibition of 47%
and 35%, at this point. At the 60 sec time point , the ISO
induced 32p incorporation into the 31 kD protein was
inhibited 23% by PIA and 60% by CARB , with the 32p incor-
poration into the 155 kD protein being reduced 25% by PIA
and 46% by CARB. By the 120 sec time point the most
evident inhibition is that of a 33% reduction in ISO
stimulated 32p incorporation of the 31kD protein in the
presence of CARB. PIA , at the 120 sec time point , showed
no effect on the ISO-induced increase in 32p incorporation
into either protein substrate.
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Figure 10. Isoproterenol time course sensitivity to
inhibition by PIA or carbachol. The effect of a 60 sec
pre-incubation with either PIA (1 ~M) or carbachol (10 ~M)
on the 15-120 sec time course sensitivity of isoproterenol(0. 1 ~M) induced 32p incorporation into myocyte proteins.
155kD protein (6A), 31kD protein (6B) . Results are
expressed relative to the isoproterenol induced incorpora-
tion and represent the mean SE for 4-10 experiments. 
asterisk denotes a significant difference compared to the
ISO value alone. A dagger denotes a significant differ-
ence compared to the appropriate ISO with PIA value.
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CONCENTRATION DEPENDENCE OF THE EFFECT OF PIA AND CARBA-
CHOL ON THE ISOPROTERENOL INDUCED 32p INCORPORATION INTO
PROTEIN SUBSTRATES. The concentration dependence of 32
incorporation was examined in myocytes preexposed (60
sec) to various concentrations of either PIA or CARB and
then exposed to different concentrations of ISO for 30
sec. While CARB can be shown to always attenuate ISO-
induced 32p incorporation , the inhibitory or stimulatory
effect of PIA appears concentration dependent. The effect
of various concentrations of PIA and CARB on the 32
incorporation induced by a 30 sec exposure to a range of
ISO concentrations (1 nM to 10 ~M) is shown in Figure 11.
All samples treated with ISO alone were significantly
different from untreated (control) cells at ISO concen -
trations above 10 nM. The effect of PIA on the ISO- in-
duced increase in 32 p incorporation in the 155kD and the
31kD proteins is shown in Figures 11A and liB. At ISO
concentrations greater than 10 nM (llA), PIA concentra-
tions of 0. 1 ~M to 10 ~M produced a significant reduction
in the ISO-induced 32p incorporation into the 155kD pro-
tein. 100 ~M PIA had no detectable effect on the ISO-
induced 32p incorporation. In the 31kD protein (liB), at
ISO concentrations greater than 10 nM, only PIA concentra-
tions of 0. 1 ~M and 1. 0 ~M produced a significant reduc-
tion in p incorporation , with the exception of 1 ~M PIA
having no effect on 1 ~M ISO. Al though only 10 ~M PIA
reduced the effect of 10 ~M ISO significantly, 100 ~M PIA
produced a significant elevation in 32p incorporation at
ISO concentrations of 0. 1 and 1 ~M.
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Figure 11. Isoproterenol induced 32p incorporation dose
response at selected concentrations of carbachol and PIA.The effect of PIA on the 32p incorporation into the 155kD
and 31kD proteins , respectively (Panels A and B). The
effect of carbachol (CARB) on the 155kD and 31kD proteins
respectively (Panels C and D). Results are expressed in
relation to untreated (control) myocytes and represent the
mean I SE of 4-12 experiments. All myocyte preparations
treated with ISO alone were significantly elevated above
control myocytes by 149% to 822% for the 31kD protein
and 146% to 238% for the 155kD protein at ISO concentra-
tions above o. 01 ~M. Significant differences are as
indicated in the Results.
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Figures 11C and liD represent the reduction by CARB
of Iso-induced 32p incorporation into the protein sub-
strates. In the 155kD protein (llC), at ISO concentra-
tions above 10 nM , all concentrations of CARB significant-
ly reduced 32p incorporation , with the exception of 1 ~M
CARB which did not significantly decrease 10 ~M ISO- in-
duced 32p incorporation. In the 31kD protein (liD), at
ISO concentrations greater than 10 nM , 1 ~M CARB signifi-
cantly reduced 32p incorporation at ISO concentrations of
10 nM and 0. 1 ~M , while CARB concentrations of 10 ~M and
100 ~M significantly reduced 32p incorporation induced by
ISO concentrations above 10 nM.
COMPARISON OF ISOPROTERENOL VERSUS FORSKOLIN INDUCED 32
INCORPORATION. Forskolin was administered to the myocytes
to examine the stimulation of protein phosphorylation
through a non-B-adrenergic receptor mediated mechanism.
While the 32p incorporation can be in excess of 800% for
both ISO and forskolin , it is evident (Figure 12) that on
an equimolar basis , 10 ~M ISO (30 sec) causes a more rapid
increase in 32 p incorporation in the 31kD substrate than
forskolin. The 31kD and the 155kD protein substrates show
an increase in 32p incorporation in response to both ISO
(0. 1 ~M , 30 & 60 sec), and forskolin (10 ~M , 30 & 60 sec;
1 ~M , 300 sec) exposure. The increase seen in 32p incor-
poration into both substrates produced by the higher
concentration (10 ~M) of forskolin is not inhibited by
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either PIA or CARB , and may in fact be potentiated by
these agents (2 of 5 experiments , data not shown).
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Figure 12. Myocyte 32p incorporation induced by isoprot-
erenol and forskolin. Ventricular myocyte ( p labeled)
protein response to agents (varied time course and concen-
tration) known to produce inotropic changes in the heart.
Results are expressed in relation to untreated (control)
myocytes. All values are significantly different from the
appropriate control values. An asterisk denotes a signif-
icant difference compared to the 30 s , O. 1 ~M ISO value.
Each treatment represents the mean I SE of 4-10 experi-
ments. ISO = isoproterenol , FSK = forskolin.
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However , the effect of 1 ~M forskolin on the 32p incorpo-
ration into 31kD protein was attenuated 25% by PIA (1 ~M)
and 44% by CARB (10 ~M), with the attenuating effect on
the 155kD protein being 12% by PIA and 31% by CARB.
SUBSTRATE IDENTIFICATION BY IMMUNOBLOTTING. The 31kD
protein substrate was found to specifically react with a
monoclonal antibody to cardiac troponin The ni trocel-
lulose transfer and autoradiograph of immunoblotting
trials used to identify the 31kD protein are shown in
Figure 13. The immunoblot in Figure 13a demonstrates a
distinct protein band appearing at an approximate molecu-
lar weight of 31kD which corresponds to the single band at
the same molecular weight in the autoradiograph shown in
Figure 13B. The absence of any appreciable 32p incorpora-
tion in Lane a of the autoradiogram and the distinct 32
incorporation in lanes b and c indicates that the 31kD
protein substrate is the cardiac regulatory protein
troponin I (TNI).
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Figure 13. Immunoblotting of the 31kD protein. A nitro-
cellulose transfer blot (panel A), exposed to a monoclonal
antibody (mouse) to skeletal muscle TNI , was developed
using a secondary antibody (goat anti-mouse) and alkaline
phosphatase system as detailed in Methods. The lowest
arrow indicates a unique staining at a molecular weight of31kD. The corresponding autoradiogram (panel B) of the
nitrocellulose blot demonstrates a distinct band at 31kD). Lane 1 represents control myocytes , while lanes 2
and 3 are myocytes exposed to 30 sec of o. 1 ~M isoprotere-
nol. In panel B , lanes a , b , and c correspond to lanes 1
, and 3 of panel A. The arrowheads indicate approximate
molecular weights in ascending order of 31kD , 68kD , 155kD
and 200kD. The typical ISO induced 32p incorporation into
the 155kD protein is seen in the upper region of panel 
The small points seen in the lower medial sections of both
panels represent registration marks for alignment of the
autoradiograph to the immunoblot.
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DISCUSSION
Numerous studies in the perfused mammalian heart
have demonstrated that the increase in the inotropic state
produced by B-adrenergic agonists is clearly related to
cAMP-dependent events resulting in the change of the
phosphorylation state of several cellular proteins
(33 109) . It is also evident that the increases in ino-
tropic state produced by B-adrenergic agonists are marked-
ly attenuated by the presence of either adenosine or
acetylcholine. In the perfused heart , both adenosine and
acetylcholine reduce the catecholamine-stimulated increase
in the 32p incorporation in several proteins in the myo-
cardium (36, 87). The perfused heart unfortunately limits
the resolution of biochemical events due to the presence
of multiple cell types. While physiologically relevant
the antiadrenergic actions of adenosine and acetylcholine
with regard to protein phosphorylation in the ventricular
myocyte have not been extensively described.
This report presents , for the first time in the
primary cultured rat ventricular myocyte , a comparison of
the attenuating effects of adenosine and acetylcholine on
the isoproterenol- induced increase in 32p incorporation
into protein substrates , cAMP levels and PKA acti vi ty.
Additionally, one of the protein substrates has been
immunologically identified as the myofibrillar regulatory
protein , troponin 
wi th the improved techniques for obtaining viable
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dispersed cell preparations from the myocardium , the study
of the biochemical events occurring at the cellular level
has been greatly facilitated (14 142). The I so- induced
increase in protein phosphorylation has been shown in the
isolated ventricular myocyte in suspension (98 101) and in
cultured cells (50).
ISO produces a time and concentration-dependent
increase in protein phosphorylation, as evidenced by an
increase in 32 p incorporation into several protein sub-
strates. As indicated in Methods , a change in 32p incor-
poration in a protein is routinely utilized as an index of
a change in the phosphorylation state of a given substrate
(25) . Consequently, the term protein phosphorylation will
be used interchangeably with 32p incorporation in discus-
sion of these findings. While protein phosphorylation has
been previously demonstrated in cellular suspensions
(98 101), the method of using adherent myocytes presents
additional evidence of physiological viability. Since it
has been shown that non-adherent cells irreversibly degen-
erate in a few hours after isolation ( 64 121), concerns
exist that observations made on myocytes in suspension may
possibly be compromised by the metabolic decline of the
cell. Furthermore , the concentrations and the time peri-
ods utilized herein were similar to those seen in earlier
reports in the perfused heart (24 97), thereby permi 
ting a comparison of a cellular event with a phenomenon
observed in the perfused heart.
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In the present investigation , no difference was seen
in the inhibition of the ISO-induced 32p incorporation by
PIA with adenosine deaminase present in the culture media.
This is contrary to a previous report (58), and may imply
that the myocytes used in this study produce little , if
any, adenosine. As a result , endogenously produced adeno-
sine by the myocytes does not appear to mask events exam-
ined in this investigation. Thus , the absence of endoge-
nous adenosine also provides additional support for the
isolated cardiomyocyte as a physiologically valuable
model.
To better understand the significance of the protein
substrates (31kD and 155kD) being affected differently by
PIA and CARB , as well as the differing sensitivities to
ISO , it is necessary to appreciate the role of these
substrates in cardiac function. The 31kD protein was
identified as TNI and it has been proposed that when
phosphorylated this protein affects the sensitivity of TNC
to calcium. Since this protein remains phosphorylated
after contractility returns to normal , this explanation
for the role of TNI has been questioned (( 112) . The 155kD
substrate is believed to be C-protein (66) and thought to
alter Mg-ATPase activity associated with the myofilaments.
Like TNI phosphorylation, the changes in phosphorylation
in C-protein accompanying B-adrenergic stimulation of the
heart have not as yet been well correlated to changes in
contractile function (46). It has even been suggested that
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the degree of dephosphorylation of TNI and c-protein may
be regulated by cholinergic stimulation in the heart (87).
The mechanism(s) underlying the greater relative
potency of CARB as compared to PIA is as yet unclear. The
reported three-fold greater density of the muscarinic
versus the adenosinergic receptors in the rat ventricle
(88) may be a component of the greater inhibitory effect
seen with the higher concentrations of CARB. However , it
is unlikely to be the sole explanation. The manner of
coupling of the receptor to transmembranal elements , in
addition to the type of cytoplasmic response elicited , may
be different. While the antiadrenergic effects of both
CARB and PIA are thought to be mediated through the GTP
binding protein G i' the proposed interaction of this
protein with the catalytic subunit of adenylyl cyclase
55), and the mechanism (s) underlying the differences
seen in response to CARB and PIA is unclear. Although
both agents reduce the ISO-induced increase in protein
phosphorylation , only CARB is able to inhibit the increase
in cAMP levels induced by catecholamine stimulation.
has been reported in the heart that muscarinic receptor
stimulation produces an increase in IP3' diacylglycerol
(DAG) and cGMP levels (11 145). The specific roles these
compounds may play in the anti adrenergic pathway is un-
known. with the well described activation of
calcium/phospholipid-dependent protein kinase C (PKC) by
DAG, and the purported action of this enzyme on adenylyl
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cyclase (5), modulation of this pathway by PKC should be
considered. Additionally, the activation of a cGMP-regu-
lated phosphatase by the increase in cGMP levels elicited
by muscarinic stimulation could also have a role in the
antiadrenergic function of carbachol (40).
The different roles of the Ai and the A2 receptors
may also explain the concentration-dependent nature of the
inhibition produced by PIA. Wi th the Ai receptor being
inhibitory and of a higher sensitivity than the stimulato-
ry, A2 receptor , it is possible that the lower concentra-
tions of PIA that produce the greatest inhibition of
phosphorylation reflect primarily Ai stimulation. The
reduced inhibition produced by the higher concentrations
of PIA could be the result of stimulation via the A
receptor in conjunction with inhibition through the A
receptor , with the result appearing simply as a reduction
in inhibition at the higher concentrations. Th i s 
further supported by evidence that the higher doses of PIA
stimulate phosphorylation in the myocyte.
It has been suggested (87) that a portion of the
inhibitory effect of acetylcholine can not be explained by
a reduction in cAMP levels but may be due to increased
dephosphorylation of phospholamban. These proposed mecha-
nisms of modulation between cAMP generation and PKA acti-
vation would provide pathways that may or may not involve
G proteins. While it has been shown that the effects of
both PIA and CARB are pertussis toxin sensi ti ve (9 55),
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the relationship between the adenosinergic and the musca-
rinic receptors and the interaction (s) of these receptors
with Gi is unclear. Whether the same molecule of Gi is
tied to both receptors types , or whether the two receptors
interact with different isoforms or "pools" of Gi remains
to be determined and could impact upon the response of the
myocyte when either or both of these agents are present.
An additional consideration resides in the concept
of cellular compartmentalization or pooling of cAMP stores
and enzymes in the myocyte. Intracellular compartmental 
zation of PKA has been suggested (14). Al though PIA was
not seen to produce an inhibition in the ISO- induced
increase in cAMP PIA was able to produce an attenuation
in the level of PKA acti vi ty caused by isoproterenol , to a
degree comparable to the inhibition produced by CARB.
is plausible that the overall level of cAMP remains rela-
tively unchanged when the catecholamine-challenged heart
is treated with PIA , yet a particular compartment of cAMP
with direct access to a specific component of a sub-cellu-
lar pool of PKA , could be preferentially reduced by the
action of PIA. This process could serve as a conveyance
of the inhibitory function without effecting global levels
of cAMP in the cell. The concept of sub-cellular compart-
mentalization is further supported by the observation that
cAMP levels produced by forskolin are markedly increased
over those seen with isoproterenol (33). However , in such
experiments the activation of PKA and protein phosphoryla-
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tions elicited by either of these agents were similar
despite the significantly smaller change in cAMP caused by
ISO.
In addition to the ability of CARB to produce a
greater inhibition of ISO-stimulated protein phosphoryla-
tion than PIA , it was noted that inhibitory effects of
CARB were seen at an earlier time point of ISO exposure
and that this inhibition was seen over a longer period of
ISO exposure than the inhibition produced by PIA. This
rapidity of action by CARB (relative to the time course of
PIA) could be due to a different sensitivity to CARB
versus PIA. However , this response could also suggest
different interactions between the transmembranal compo-
nents of the B-adrenergic system and the muscarinic system
versus the adenosinergic system.
The increase in protein phosphorylation induced by
forskolin is of interest for several reasons. Wi th an
established effect in the perfused heart (33), the use of
forskolin was initially intended to demonstrate a mecha-
nism , other than B-adrenergic receptor mediated, by which
protein phosphorylation could be stimulated in the myo-
cyte . Since the site of action of forskolin in the myo-
cyte was believed to be directly upon the catalytic subu-
nit of the adenylyl cyclase complex (124), it was thought
that forskolin stimulation would not be inhibited by
ei ther PIA or CARB. While at higher concentrations of
forskolin no inhibition by PIA or CARB was noted , the
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stimulation of protein phosphorylation seen with lower
concentrations of forskolin was inhibited by PIA and
carbachol. This observation supports recent findings in
primary cultured myocyte membrane preparations (116) that
PIA inhibition of forskolin-stimulated adenylyl cyclase
acti vi ty occurs , over a narrower range of forskolin con-
centration , and to a lesser degree than did the inhibition
by PIA of ISo-stimulated adenylyl cyclase acti vi ty. This
raises a question concerning the mechanism(s) of action of
forskolin. While little is understood about the
action(s) of forskolin , it has been suggested that the
myocyte may possess a forskolin receptor (119), a factor
which may serve as a component of the concentration-de-
pendent sensitivity of forskolin to PIA and CARB by pro-
viding a site in addition to the purported direct site of
action of forskolin on the catalytic subunit of adenylyl
cyclase (140). It has also been suggested that forskolin
may interact directly with the G protein (146). Should
forskolin present multiple sites of action or multiple
affinities for the same site , this inotropic agent may be
included in the list of agonists susceptible to the ef-
fects of certain antiadrenergic agents.
The identification by immunoblotting of the protein
phosphorylated by ISO provides strong evidence that this
protein is a component of the myofilament system of the
myocyte. Both TNI and C-protein have been shown to be
substrates of PKA, as well as other kinases associated
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with the myocardium (5 40). Al though the function of
these proteins in the myocardium is not well understood,
their association with the contractile apparatus and their
covalent modification by catecholamine induced phosphory-
lation may imply a physiological role (25 46). Addi tion-
ally, when the long term period of dephosphorylation of
these proteins is contrasted to the more rapid dephospho-
rylation reported for phospholamban (40), a role in the
contractile process may be envisioned. In that TNI and
protein are known to be phosphorylated in the catechola-
mine treated heart , and the period of increased phosphory-
lation lasts well after the removal of the catecholamine
(40), these proteins may have a role in developing a
preferential or permissive state" for a rapid change in
inotropy. In this preferential state , the more rapid
adjustments in inotropic state would be the result of
proteins such as phospholamban , controlling real-time
calcium levels and thereby adjusting "beat to beat" ino-
tropic state. This would be consistent with the observa-
tion that both TNI and C-protein remain phosphorylated
long after the increase in inotropic state produced by
catecholamines is diminished by the removal of the catech-
olamine (123).
In summary, this investigation has demonstrated
that troponin I and a 155kD protein , possibly C-protein
are phosphorylated in the presence of ISO in the myocyte
and that these phosphorylations are attenuated by the
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adenosinergic agonist , PIA , as well as the muscarinic
agonist , carbachol. Additionally, it was shown that CARB
produces a greater inhibitory effect on the ISO induced
phosphorylation of these proteins than PIA. Forskolin has
also been shown to produce similar increases in phosphory-
lation, with PIA and carbachol able to reduce these in-
creases , although to a lesser degree than the reduction of
ISO-induced increases in phosphorylation. While a major
component of the antiadrenergic properties of these agents
is felt to be mediated through the transmembrane protein
i' the degree to which carbachol more effectively inhib-
its ISo- induced protein phosphorylation suggests a more
complex mechanism of inhibition to perhaps include multi-
pIe sites of action.
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CHAPTER V
CONCLUSION
The regulation of myocardial contractility and
metabolism involves mechanisms unique to cardiac muscle as
well as those common to all muscle types. A pr imary
mechanism common to all types of muscle involves intracel-
lular transduction and amplification of signals by revers-
ible covalent modification of proteins by phosphorylation.
This mechanism of modification , resulting from a conforma-
tional change in protein structure brought about by phosp-
horylation , can produce either an activation or an inhibi-
tion of selected protein function.
Studies of cyclic oscillations of cAMP-related events
durinq the contraction cycle Since the basic mechanism
of muscle contraction is known to involve changes in the
phosphorylation state of cellular proteins (141), the
nature of these covalent modifications and the manner by
which these changes are brought about appear to be an
integral part of the regulation of myocardial metabolism
and contractility. To better understand the role of
protein phosphorylation in the regulation of cardiac
contractility and metabolism , the myocardium was initially
examined in view of the uniquely cyclic property of con-
traction in the heart. A device capable of arresting the
perfused rat heart in less than 50 milliseconds (134) was
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utilized to investigate changes in cAMP and in the activi-
ty of 2 cAMP-dependent enzymes dur ing the cardiac contrac-
tion cycle. By measuring these parameters at different
points (within the cycle) we could determine whether or
not cAMP-dependent changes underlie metabolic events that
occur during contraction.
The results from these studies revealed no changes
in cAMP levels , or in the acti vi ties of cAMP-dependent
protein kinase or glycogen phosphorylase during a single
contraction cycle. This finding conflicts with earlier
reports suggesting that cyclic AMP levels and glycogen
phosphorylase activity change as a function of the con-
traction cycle (134 144). However , the nature and degree of
the changes reported , in addition to the experimental
designs utilized, present certain concerns as to the
physiological significance of such findings. For example
in one of these studies employing perfused rat heart
myocardial tissue was subjected to field stimulation and
such conditions may have evoked release of endogenous
catecholamine (10). In another investigation in the rat
(134) the variation in glycogen phosphorylase activity
during the contraction cycle was examined at lower than
physiological temperatures and in the presence of mechani-
cal and pharmacological interventions to elongate the
single contraction cycle. other studies that demonstrated
cyclical changes in cAMP , ATP , ADP , glucose-6-phosphate
pyruvate , phosphocreatine , and creatine employed nanomolar
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levels of isoproterenol , high calcium and glucose in the
perfusate , coupled with increased afterload pressure.
These changes were not observed in pyruvate perfused rat
hearts (141). In another study on metabolic change during
the cardiac cycle in the dog heart transient changes in
cAMP levels and in the activities of cAMP-dependent pro-
tein kinase and glycogen phosphorylase were noted during
the contraction cycle. However , propanolol treatment
abolished the fluctuations in cAMP and cAMP-dependent
protein kinase , while having no effect on the fluctuations
demonstrated by glycogen phosphorylase (78). Thus it
seems likely that the variation in cAMP and cAMP-dependent
protein kinase results from a beat to beat fluctuation in
endogenous catecholamine release.
These technical concerns force us to conclude that
more rigorous tests must be employed to demonstrate that
oscillatory changes in energy-related events occur in the
functioning myocardium. While certain events such as
calcium flux (83) and conformational changes in the
contractile proteins (70) are known to occur in a cyclic
manner during the contraction cycle , the oscillatory
nature of other events , such as cAMP , ATP , and ADP levels
and additional elements associated with myocardial metabo-
lism are not as clearly understood. The cycl ic manner 
myocardial contraction suggests that certain biochemical
events must oscillate during a single heart beat. Howev-
, the extremely short time course of contraction in the
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mammalian heart , and the fact that a subtle biochemical
change might evoke a marked physiologicial effect in
myocardial function , make this technically difficult.
Additionally, it is possible that cyclic changes occur
only in specific sub-cellular compartments such that these
changes are obscured when analyses measure the levels of
metabolites in whole cells or organs.
The existence of compartments , while diff icul t 
demonstrate , is readily inferred. Although forskolin will
increase myocardial cAMP levels to much higher concentra-
tions than those evoked by isoproterenol , the activation
of cAMP dependent protein kinase by isoproterenol occurs
more rapidly and to a greater extent than the activation
by forskolin (33). prostaglandin E1 produces an elevation
in cAMP levels and activates cAMP-dependent protein kinase
in the heart. However , these increases do not appear to
effect the contractile state of the heart (51).
explain the differences in response to these agents
(isoproterenol , forskolin, prostaglandin), it has been
suggested that ISO but not forskolin or PGE elicits an
increase in cAMP in a sub-cellular compartment (s) of cAMP
that has preferential access to cAMP-dependent protein
kinase. Since a change in contractile state is only
observed with isoproterenol and forskolin , it is evident
that protein phosphorylation is integral in the mechanism.
Cyclic AMP-dependent and calcium/phospholipid-de-
pendent protein kinases trans locate from particulate to
soluble and from soluble to particulate fractions of a
cell , respectively, during catecholamine stimulated acti-
vat ion (53). . This suggests that elements of a cell may
occupy a certain compartment or domain within the cell
and , upon activation or stimulation, may relocate to a
different compartment to perform a given role.
Chapter Selected Protein Kinases and Substrates in the
Myocardi um Protein kinases as cellular effectors in the
myocardium provide a mechanism of translation of extracel-
lular and intracellular signals into intracellular re-
sponses. In addition to the role as intracellular media-
tors , protein kinases also provide potential sites of
regulation. The acti vi ties of cAMP-dependent
calcium/ calmodulin-dependent , calcium/phospholipid-depend-
ent and cGMP-dependent protein kinases determined in a
canine cardiac sarcolemmal preparation demonstrate the
relative influence of these enzymes , with cAMP-dependent
protein kinase being the most active. Additionally, these
kinases were found to phosphorylate endogenous protein
substrates in this preparation with particular substrates
phosphorylated by 2 or more kinases. Since cAMP-dependent
protein kinase had the greatest activity and since it
produced the greatest degree of endogenous protein phosp-
horylation , it seems likely that cAMP-dependent protein
kinase exerts the most influence with respect to myocar-
dial metabolism.
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since the kinases examined appear to act on the same
subsubstrate (s), it would be of interest to determine
whether these enzymes act in a complimentary or related
manner. Cyclic AMP-dependent protein kinase may provide
the principle or initiating effect by phosphorylation of a
substrate. Another kinase , such as calcium/ calmodulin-
dependent protein kinase may then serve to intensify or
prolong the effect produced by covalent modification of a
given substrate. This interdependence could also provide
a means for different second messengers , such as cAMP and
calcium , to produce similar or complimentary effects
through different cellular pathways. wi th the change in
cAMP-dependent protein kinase isoforms that occur in the
diseased myocardium (105) , it is conceivable that a second
kinase , such as calcium/calmodulin-dependent kinase , may
increase in acti vi ty to counter a change in cAMP-dependent
protein kinase activity. This overlap in enzyme function
could provide a reserve of kinase activity. This reserve
could also serve to limit the effect of the saturation of
a given kinase and increase the rate of response of a
particular system by (simultaneous) activation of multiple
kinases.
since cAMP-dependent protein kinase , calcium/phos-
pholipid-dependent protein kinase and calcium/calmodulin-
dependent protein kinase have been shown to have specific
actions at the level of the sarcolemma (63 106 138), the
probability of these kinases being present as a result of
121
a preparational artifact appears minimal. Cyclic AMP-
dependent protein kinase , probably the most closely exam-
ined in the myocardium has been implicated in the shown
phosphorylation of a protein substrate that is closely
associated with the sarcolemmal calcium channel (125).
Additionally, electrophysiological investigation has
demonstrated a direct correlation between the presence of
the catalytic subunit of cAMP-dependent protein kinase and
an increase in calcium flux through the voltage sensitive
calcium channel (69 147). Ca 1 c i um/ phosphol ip id -dependent
protein kinase and calcium/calmodulin-dependent protein
kinase phosphorylate a cytoplasmic face sarcolemmal pro-
tein (63).
since changes in phosphorylation states of protein
substrates alter myocardial metabolism and contractility,
understanding the particular proteins that are phosphory-
lated and the manner in which these phosphorylations are
regulated could provide a more direct appreciation of
kinase-related cellular events in the myocardium.
protein PhosphorYlation in the Isolated Myocyte While
the perfused heart provides an excellent means for compar-
ing of functional parameters of the working heart with
biochemical changes in the organ , the multiple cell types
present in the organ eliminate the possibility of ascrib-
ing a particular change to a specific cell type. Viable
dispersed ventricular myocytes offer the opportunity to
discern the specific metabolic events that occur in cardi-
. I
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ac cells under various physiological conditions. These
conditions led us to reexamine the effects of catechola-
mine stimulation on protein kinase acti vi ty and protein
phosphorylation in ventricular myocytes and to assess the
effects of acetylcholine and adenosine on B-adrenergic
response.
These studies demonstrated that B-adrenergic stimu-
lation of ventricular myocytes elicits an increase in cAMP
levels and in cAMP-dependent protein kinase acti vi ty that
results in phosphorylation of phospholamban, troponin I
and a protein felt to be C-protein in the isolated ven-
tricular myocyte , changes similar to those described
previously in the perfused heart (40). When myocytes are
pretreated to the antiadrenergic agents carbachol and
phenylisopropyl adenosine , prior to the introduction of
catecholamine , the effects of the catecholamine are in
general attenuated. Exposure of the myocytes to the
di terpene, forskolin, produces somewhat larger increases
in cAMP but comparable changes in contractility as com-
pared to the case with catecholamines , a finding similar
to that seen in the perfused heart (33).
There is an interesting exception to the antiadre-
nergic role of carbachol and phenylisopropyl adenosine in
the myocyte when compared to that seen in the perfused
heart. While carbachol and phenyl isopropyl adenosine
attenuate catecholamine- induced effects in the perfused
heart , the nature and scope of the effect of phenylisopro-
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pyl adenosine in the isolated myocyte vary in relation to
concentration. At lower concentrations of adenosine , the
effect of catecholamines on cAMP-dependent protein kinase
and protein phosphorylation in the heart are reduced
while cAMP levels are unchanged from those levels seen
with catecholamine stimulation. At elevated levels of
phenylisopropyl adenosine, catecholamine- induced increases
in protein phosphorylation appear to be potentiated.
nergic receptor subtypes present in the myocardium. The
The opposite effects of phenylisopropyl adenosine on
catecholamine-induced events in the myocyte may be ex-
plained by the differences in the two different adenosi-
i subtype, presumably coupled to adenylyl cyclase via the
nucleotide binding protein Gi ' inhibits adenylyl cyclase
activity and this inhibitory effect is seen at relatively
low concentrations of adenosine (Kd 1. 2 nmol for PIA) .
The A2 subtype , presumably coupled to adenylyl cyclase via
s stimulates adenylyl cyclase , but relatively high con-
centrations of adenosine (Kd 120 nmol for PIA) are re-
quired to elicit this response (116). Consequently, lower
doses of phenyl isopropyl adenosine are inhibitory with
regard to catecholamine-induced effects in the myocyte
while higher phenylisopropyl adenosine concentrations
produce stimulatory effects with regard to adenylyl cy-
clase that may be complimentary to those produced by the
catecholamine.
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To understand why a single agonist interacts with
two different receptor subtypes to elicit opposite effects
in the same cell type, one needs to appreciate the dynam-
ics of adenosine metabolism in the myocardium. with
catecholamine stimulation , the level of adenosine in-
creases due to the increased metabolic activity. This
rise in adenosine acting via Ai receptors can act as a
feedback inhibitor, limiting the catecholamine- induced
increases in metabolism (22 23). This is suggested by the
increase in catecholamine stimulation of the oxygenated
heart increasing adenosine levels and possibly preventing
over stimulation of the heart (28). If catecholamine
stimulation becomes excessive as may occur in the failing
heart (105), the correspondingly higher adenosine levels
(26) may activate A2 receptors , potentiating catechola-
mine action. This mechanism could be envisioned as a
final effort to maintain a minimal level of mechanical
induced increases in cAMP levels. Al though carbachol and
acti vi ty by a diseased organ.
A second difference regarding the antiadrenergic
actions of carbachol and phenyl isopropyl adenosine in-
volves the influence of these agents on catecholamine-
phenyl isopropyl adenosine both reduce PKA and PKA-depend-
ent protein phosphorylation , only carbachol reduces the
increase in cAMP levels evoked by catecholamines in the
myocyte. This difference may be attributable to the
additional effects of muscarinic agents to increase dia-
cylglycerol and IP3 release , and stimulate phosphodiester-
ase activity (95 145). PIA, on the other hand has no known
effect on PI turnover although it inhibits adenylyl cy-
clase (84). The finding that PIA failed to attenuate
catecholamine-stimulated cAMP levels in the myocyte dif-
fers from the findings in perfused heart. The explanation
for this discrepancy is unclear and may reflect prepara-
tional differences or an effect on phosphodiesterases in
the myocardium since high levels of adenosine analogues
inhibit phosphodiesterase (95). Such an inhibition could
mask a localized change in cAMP levels evoked by phenyli-
sopropyl adenosine. Thus , the contrasting effects on
phosphodiesterase activity of these antiadrenergic agents
may provide a basis for the differing effects regarding
isoproterenol-induced cAMP levels.
IV. continued Studies. Since carbachol and adenosine
have different effects on phosphoinositol turnover , it is
possible that phosphoinositol metabolism represents anoth-
er inhibitory pathway that leads to the reduction in cAMP
seen in the presence of carbachol. Since diacylglycerol
activates protein kinase C (131), the antiadrenergic
effects of carbachol could be in part mediated by this
protein kinase. Additionally, subcellular compartmentali-
zation may underlie the different actions of these two
agonists. Phenylisopropyl adenosine may act to inhibit a
small pool of adenylyl cyclase in a compartment with
preferential access to cAMP-dependent protein kinase
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while carbachol may interact with a larger pool of cyclase
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such that it produces more marked changes in total cellu-
lar cAMP , only a small fraction of which may be involved
in regulating cAMP-dependent protein kinase. Also , the
ability of carbachol to stimulate phosphodiesterase acti 
ity (8) may contribute to the reduction in cAMP levels.
This effect of carbachol on phosphodiesterase acti vi ty 
in contrast to the effects of high concentrations of
phenylisopropyl adenosine which inhibit phosphodiesterase
activity in the perfused heart (95).
The speculation concerning the differential effects
regarding cAMP levels of these two antiadrenergic agonists
may extended to be consider the manner in which the musca-
rinic and the adenosinergic receptors are coupled to the
membrane bound adenylyl cyclase (116, 145). Whether there
is a preferential coupling of the muscarinic receptor or a
greater number of muscarinic receptors linked to the
adenylyl cyclase is unclear. Since the manner of interac-
tion within the receptor , G protein, adenylyl cyclase
complex is not well understood for either the muscarinic
or adenosinergic receptors , the relative differences in
their inhibition of adenylyl cyclase is as yet unex-
plained. Further examination (88) to correlate receptor
densi ties (Ai vs M2)' with the relative effects of equimo-
lar amounts of phenyl isopropyl adenosine and carbachol
would provide insight regarding the relative efficacies of
these antiadrenergic agents.
! I
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Signif icant attention has been directed toward
transmembranal events associated with adrenergic and
antiadrenergic activity (123). A complimentary approach to
understanding antiadrenergic mechanisms may lie in examin-
ing intracellular responses to antiadrenergic agents.
dependent protein kinase , respectively (43 131). These
this manner a change in a cellular component , such as a
kinase or a phosphoprotein could be associated with a
particular agonist.
Phenyl isopropyl adenosine and carbachol inhibit the
isoproterenol-induced increase in the phosphorylation of
certain protein substrates in the heart , presumably by
reducing cAMP-dependent protein kinase acti vi ty. Carba-
chol also produces an elevation of diacylglycerol and cGMP
levels in the heart (145), known activators of
calcium/phospholipid-dependent protein kinase and cGMP-
additional effects of muscarinic agonists (when compared
to the effect of phenylisopropyl adenosine) may be a basis
for the different degree and manner of antiadrenergic
response produced by these agonists. Investigation of the
action of these kinases in the presence of a selective
inhibi tor to CAMP-dependent protein kinase to identify
cellular substrates and intracellular domains could pro-
vide information to differentiate between the actions of
phenyl isopropyl adenosine and carbachol. In this manner
it may be possible to identify the nature and extent of
modulation of various cellular elements by these agents.
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in the myocyte (14). This partitioning may also be evi-
since catecholaamine stimulation leads to a translo-
cation of cAMP-dependent protein kinase from the particu-
late or membrane associated sub-cellular fraction to the
cytoplasmic or soluble fraction (53) it seems likely that
cellular compartmentalization or regionalization may exist
dent regarding the distribution of certain protein kinases
and intracellular messengers in the myocyte , and it is
possible that further examination could reveal differen-
tial effects of agonists based on access to various com-
partments .
A preliminary test of compartmentalization in the
myocyte could be performed using existing techniques.
Differential centrifugation of 32p labelled myocytes
treated with catecholamines in the presence and absence of
carbachol or phenylisopropyl adenosine should provide
strong indication of any regionalization of agonist ef-
fect. Autoradiographic analysis of cellular proteins,
determination of protein kinase activities and the levels
of intracellular messengers would permit the construction
of a cell map. In this manner variations in quantities
locations of cellular effectors and the correlation of any
changes to structures wi thin the myocyte could be ex-
pressed as a function of sub-cellular locale.
The multiple effects of the cardiac muscarinic
receptor (145) could be examined in view of the activation
of diacylglycerol release , the reduction in
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catecholamine-stimulated cAMP levels and the stimulation
of cGMP in the myocyte. since DAG and cGMP are known to
activate PKC and cGMP-dependent protein kinase, changes in
the activity of these enzymes under the conditions men-
tioned earlier could provide an insight to the role of
non-cAMP-dependent pathways in the antiadrenergic role of
carbachol.
The different effects of the adenosinergic receptors
could also be examined in a similar framework. Currently
available Ai and A2 agonists and antagonists could be used
to selectively observe the response to each adenosinergic
receptor subtype. In view of the stimulatory nature of
the A2 with respect to adenylyl cyclase , it is possible
that the antiadrenergic effects of phenylisopropyl adeno-
sine may not be completely understood since the Ai re-
sponse may be damped (dampened) by an A2 mediated compo-
nent. while these two opposing systems may serve syner-
gistically in vivo, a better understanding of underlying
mechanisms could result from the ability to examine each
subtype in the absence of the other. using an A2 specific
antagonist , it would be possible to strictly examine the
elicited effects of phenyl isopropyl adenosine. Simi-
larly, the use of an Ai antagonist would allow examination
of the stimulatory effects of adenosine. Combining the A
antagonist with an inhibitor of protein kinase A could
demonstrate the degree of similarity between A 2 and 
mediated stimulation of adenylyl cyclase.
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wi th a more complete appreciation of the individual
functions of these antiadrenergic activities in the myo-
cyte , it would be possible to consider the manner in which
these elements may interact to modulate myocardial metabo-
lism and contractility.
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APPENDIX
MYOCYTE ISOLATION: Isolated , calcium tolerant ventricular
myocytes were prepared as previously described (Romano
at 7. 4 by constant gassing with 95% 0 -5% C0 After an
, AJP). In brief, hearts were excised from decapitated
adult male rats (250-350g) and immediately perfused at
C via an aortic cannula at constant pressure (70 mm
0) using physiological saline (PSS) conta ning in milli-
molar amounts; 119. 4 NaCl , 4. 7 KCl , 25 CaC12' 10 glucose
25 NaHC03' 1. 2 MgS04 and 1. 2 KH 4. The pH was maintained
equilibration period of approximately 12 minutes , the
hearts were stopped by means of a 60 second period of
perfusion with calcium free PSS , whereupon a solution
containing 0. 80% collagenase , 0. 30% hyaluronidase , 0. 10%
a constant flow rate of 3. 5 ml per minute per heart.
bovine serum albumin (BSA) and 50 MM CaC12 was perfused at
the first sign of surface striations (usually within 7-10
minutes), the ventricles were removed from the cannula
longitudinally quartered and placed in a flask containing
80% collagenase , 0. 30% hyaluronidase , 0. 25% BSA and 50
~M CaC12 for gentle agitation at 370 (40 cyclesjmin)
while gassed with 95% 0 -5%C0 The media was gently
removed by aspiration every 7 min and replaced with fresh
media for a total of 3-5 changes per preparation. When
the sections began to appear soft and stringy and tore
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easily when held by forceps , the media was again changed
and the flask was rapidly agitated , under the same condi-
tions as noted before , for 10 min. The contents of the
flask was then strained through a nylon mesh (pore size
250 micron), washed with a solution of 0. 60% BSA and 100
~M CaC1 (WASH) and allowed to settle at room temperature
for 15 min. The upper two-thirds of the WASH was gently
removed by aspiration and replaced with 40 ml of fresh
WASH for a second 15 min settling. The WASH solution was
removed as close to the pellet as practicle and replaced
with 40 ml of media M199 (Gibco: 25 ro NaHC03' 25 ro
HEPES , EARLE'S salts) for an additional settling of 10
min. The supernatant was removed and replaced with fresh
M199 of a volume to permit plating on polystyrene culture
dishes at an approximate final density cell density of
20-30 cells per high power (300X) microscope field.
CuI ture dishes were pre incubated for 4 hours with M199
supplemented with heat inactivated fetal calf serum (FCS
Gibco) to provide a final concentration of approximately
4% FCS. Dishes were maintained from the pre- incubation
phase through completion of the experiment in a humidi-
fied , quick recovery incubator (37 C) under constant
gassing with a 5% C0 room air mixture. Preparations that
did not yield a minimum of 75% rod shaped cells as deter-
mined by microscopic inspection at final settling were
discarded.
References
1. BAZZI , M. D., P. D. LAMPE, G. M. STRASBERG, and G.
NELSESTUEN. Phosphorylation of troponin I by protein
kinase C: mechanism of inhibition by calmodulin and tropo-
nin C. Biochim. BioPhys. Acta 931:339-346 , 1987.
2. BENOVIC , J. L., C. STANISZEWSKI, F. JR. MAYOR , M.
CARON, and R. J. LEFKOWITZ. a-adrenergic receptor kinase.
J. Biol. Chem. 263:3893-3897 1988.
3. BESSMAN , S. P., and P. J. GEIGER. Transport of energy
in muscle: The phosphorylcreatine shuttle. Science
211: 448-452 , 1981.
4. BODE , D. C. , and L. L. BRUNTON. Adrenergic, cho iner-
gic, and other hormone receptors on cardiac myocytes. In:
Isolated adult cardiomyocvtes: Structure and Metabolism
(edited by PIPER , H. , and G. ISENBERG). Boca Raton:CRC
Press , 1989 , p. 164-201.
5. BOHM , M. , W. SCHMITZ, H. SCHOLZ , and A. WILKEN.
Pertussis toxin prevents adenosine receptor- and m-choli-
nergic-mediated sinus rate slowing and AV conduction block
in the guinea- pig heart. Naum. -Schmied. Arch Pharm.
339: 152-158 , 1989.
6. BROOKER, G. Oscillations of cyclic adenosine mono-
phosphate concentration during the myocardial contraction
cycle. Science 182:933-934 , 1973.
133
134
7. BROWN , J. H. , I. L. 0 . BUXTON , and L. L. BRUNTON. 
adrenergic and muscarinic cholinergic stimulation of
phosphoinosi tide hydrolysis in adult rat cardiomyocytes.
Circ. Res. 57:532-587 , 1985.
8. BROWN , J. H. , and D. GOLDSTEIN. Differences in musca-
rinic reserve for inhibition of adenylate cyclase and
stimulation of phophoinosi tide hydrolysis in chick heart
cells. Mol. Pharmacol. 30: 566-570 , 1986.
9. BRUNTON , L. , J. S. HAYES, and S. E. MAYER. Hormonally
specific phosphorylation of cardiac troponin I and activa-
tion of glycogen phosphorylase. Nature 280: 78-80 , 1979.
10. BUXTON, I. L. 0., and L. L. BRUNTON. Compartments of
cyclic AMP and protein kinase in mammaliam cardiomyocytes.
J. Biol. Chem. 258:10233-10239 , 1983.
11. CARON I , P., and E. CARAFOLI. Regulation of calcium-
pumping ATPase of heart sarcolemma by a phosphorylation-
dephosphorylation process. J. Biol. Chem. 256:9371-9378
1981.
12. CARONI , P., and E. CARAFOLI. The calcium pumping
ATPase of heart sarcolemma: characterizationcalmodulin
dependence and partial purification. J. Biol. Chem.
256:3263-3270 , 1981.
135
13. CHENG , H. -C. , B. E. KEMP , R. B. PEARSON, A. J. SMITH , L.
MISCONI , S. M. VAN PATTEN , and D. A. WALSH. A potent syn-
thetic inhibitor of the cAMP-dependent protein kinase.
J. Biol. Chem. 261:989-992, 1986.
14. COGOLI , J. M. , and J. G. JR. DOBSON. An easy and rapid
method for the measurement of ( 32pJATP specific radioac-
ti vi ty in tissue extracts obtained from in vitro rat heart
preparations labelled with pi. Anal. Biochem. 110: 331-337 ,
1981.
15. COHEN , P., D. B. RYLATT , and G. A. NIMMO. The hormonal
control of glycogen metabolism: the amino acid sequence at
the phosphorylation site of protein phosphatase
inhibitor-i. FEBS Lett. 76:182-198 , 1977.
16. CORBIN , J. , P. R. SUGDEN , T. M. LINCOLN , and S.
KEELY. compartmentalization of adenosine 3' : 5' - monophos-
phate-dependent protein kinase in heart tissue. J. Bioch.
Chem. 252: 3854-3861, 1977.
17. DOBSON , J. , JR. The effect of acetylcholine , ische-
mia, and anoxia on rat heart purine cyclic nucleotides and
contractility. Circ. Res. 49:912-922 , 1981.
18. DOBSON , J. , JR. Mechanism of adenosine inhibition
of catecholamine- induced responses in the heart. Circ.
Res. 52:151-160 1983.
. '
136
23. DOBSON, J. G. JR., R. A. FENTON, and F. D. ROMAO. The
19. DOBSON , J. G., JR. , R. A. FENTON , and F. D. ROMAO. The
anti-adrenergic actions of adenosine in the heart. In:
Topics and Perspectives in Adenosine Research , (edited by
GERLACH, E. , and B. F. BECKER). New York: springer-Verlag,
1987 , p. 356-368.
20. DOBSON , J. G. JR. Protein kinase regulation of cardiac
phosphorylase activity and contractility. Am. J. Phvsiol.
234:H638-H645 , 1978.
21. DOBSON , J. JR. Catecholamine- induced phosphorylation
of cardiac muscle proteins. Bioch. Biophvs. Acta.
675:123-131 , 1981.
22. DOBSON, J. JR., R. A. FENTON, and F. D. ROMANO. Re-
duced contractile response to Beta-adrenergic stimulation
in the aged heart is associated with an elevated increase
of myocardial adenosine. Fed. Proc. 45:750 , 1986.
cardiac anti-adrenergic effect of adenosine. In: Cardiac
electrophvSioloqv and pharmacoloqv of adenosine and ATP:
Basic and clinical aspects , (edited by PELLEG, A., E.
MICHELSON , and L. S. DREIFUS). New York:Liss R., 1987
p. 331-343.
24. DOBSON, J. G. JR. , R. A. FENTON , and F. D. ROMANO. The
anti-adrenergic actions of adenosine in the heart. In:
Topics and perspectives in adenosine research , ( edited 
GERLACH, E. , and B. F. BECKER). Berlin: Springer-Verlag,
1987 , p. 356-368.
25. DOBSON, J. G. JR., J. JR. ROSS , and S. MAYER. The role
of cyclic adenosine 3 1 5 '-monophosphate and calcium in the
regulation of contractility and glycogen phosphorylase
activity in guinea pig papillary muscle. Circ. Res.
39:388-395, 1976.
26. ENDO, M. Calcium release from the sarcoplasmic retic-
ulum. Physiological Reviews 57: 71-106, 1977.
27. ENGLAND , P. J. Studies on the phosphorylation of the
inhibitory subunit of troponin during modification of
contraction in perfused rat heart. Bioch. J. 160:295-304
1976.
28. ENGLAND , P. J. Phosphorylation of the inhibitory
subuni t of troponin in mice deficient in phosphorylase
kinase. Bioch. J. 168: 307-315 , 1977.
29. ENGLAND , P. J., and M. SHAHID. Effects of forskolin on
contractile responses and protein phosphorylation in the
isolated perfused rat heart. Bioch. J. 246:687-695, 1987.
137
138
30. FABIATO , A. Release of calcium from the sarcoplasmic
reticulum. In: Cardiac muscle: The requlation of excita-
tion and contraction , (edited by NATHAN , R.
34. FOSSEL , E. T., H. E. MORGAN , and J. S. INGWALL. Measure-
Orlando:Academic Press , 1986, p. 283-296.
31. FABIATO , A. , and F. FABIATO. Calcium and cardiac
excitation- contraction coupling. Ann. Rev. Physiol.
41:473-516 , 1979.
32. FENTON , R. , and J. G. , JR. DOBSON. Adenosine and
calcium alter adrenergic-induced intact heart protein
phosphorylation. Am. J. Physiol. 246 :H559-H565 , 1984.
33. FERRARI, S., F.. MARCHIORI, G. BORIN , and L. A. PINNA.
Distinct structural requirements of Ca2+ /phospholipid-
dependent protein kinase (protein kinase C) and cAMP-
dependent protein kinase as evidenced by synthetic peptide
ili
substrates. FEBS Letters 184: 72-77 , 1985.
ment of changes in high-energy phosphates in the cardiac
cycle by using gated 31 p nuclear magnetic resonance. Proc.
Nat. Acad. Sci. 77:3654-3658 , 1980.
35. FRIEDMAN , D. L., and J. LARNER. Studies on UDPG-
glucan transglucogylase III. Interconversion of two forms
of muscle UDPG- glucan transglucogylase by a phosphoryl 
tion-dephosphorylation reaction sequence. Biochemistry
2: 669-678 , 1963.
139
36. GARVEY, J. L., E. G. KRANIAS , and R. J SOLARO. Phospho-
39. GLASS , D. B. , and E. G. KREBS. Phosphorylation by
rylation of C-protein, troponin I and phospholamban in
isolated rabbit hearts. Bioch. J. 249:709-714 , 1988.
37. GILBOE , D. P. , K. L. LARSON, and F. Q. NUTTALL. Radioac-
ti ve method for the assay of glycogen phosphorylase. Anal.
Bioch. 47:20-27 , 1972.
38. GILMAN , A. G. G: proteins: Transducers of receptor
generated signals. Ann. Rev. Bioch. 56: 615-649 , 1987.
guanosine 3 I : 5 I -dependent protein kinase of synthetic
peptide analogs of a site phosphorylated in histone 2b.
J. Biol. Chem. 257: 1196-1200 , 1982.
40. HARDMAN , J. , S. E. MAYER, and B. CLARK. Cocaine
potentiation of the cardiac inotropic and phosphorylase
response to catecholamines as related to the uptake of 3 H
catecholamines. J. Pharm. and Exp. Ther. 150:341-348
1965.
41. HARLOW , E. , and D. LANE. Immunoblotting. In: Anti-
bodies: a laboratory manual , (edited by HARLOW , E., and D.
LANE). Cold spring: Cold spring harbor laboratory, 1988
p. 471-510.
42. HARTZELL, H. C. Effects of phosphorylated and unphosp-
horylated c-protein on cardiac actomyosin ATPase.
J. Mol. BioI. 186: 185-195 , 1985.
140
43. HARTZELL, H. C., and L. TITUS. Effects of cholinergic
and adrenergic agonists on the phosphorylation of a
165 000-dalton myofibrillar protein in intact cardiac
muscle. J. Biol. Chem. 257:2111-2120 , 1982.
44. HASCHKE, R. H. , L. M. HEILMEYER, F. MEYER, and E. H.
FISCHER. control of phosphorylase activity in a muscle
glycogen particle III. J. Biol. Chem. 245: 6657-6666 , 1970.
45. HAYES, J. S. Coordination of cardiac contractility and
metabolism by protein phosphorylation. In: Protein phosp-
horvlation in heart muscle (edi ted by SOLARO , R. J. ). Boca
Ratan:CRC Press , 1985, p. 17-54.
46. HAYES, J. S., N. BOWLING , and G. B. BODER. Contractili-
ty and protein phosphorylation in cardiomyocytes: effects
of isoproterenol and AR-L57. Am. J. Phvsiol. 247:H157-
H169 , 1984.
47. HAYES, J. S., N. BOWLING , K. L. KING , and G. B. BODER.
Evidence for selective regulation of the phosphorylation
of of myocyte proteins by isoproterenol and prostaglandin
1. 
Bioch. Biophvs. Acta 714: 136-142 , 1982.
48. HAYES, J. , L. L. BRUNTON , J. H. BROWN, J. B. REESE
and S. E. MAYER. Hormonally specific expression of cardiac
protein kinase activity. Proc. Nat. Acad. Sci. 76:1570-
1574 , 1979.
141
accumulation in isolated rat heart cells. J. BioI. Chem.
49. HAYES , J. , L. L. BRUNTON , and S. E. MAYER. Selective
activation of particulate cAMP-dependent protein kinase by
isoproterenol and PGE 1. J. Biol. Chem. 255: 5113-5119,
1980.
50. HAYES , J. , and S. E. MAYER. Regulation of guinea pig
heart phosphorylase kinase by cAMP , protein kinase , and
calcium. Am. J. Phvsiol. 240:E340-E348 , 1981.
51. HAZEKI , 0. , and M. UI. Modification by islet-activat-
ing protein of receptor-mediated regulation of cyclic AMP
256: 2856-2862, 1981.
52. HEASLEY , L. E. , and G. L. JOHNSON. Regulation of pro-
tein kinse C by nerve growth factor, epidermal growth
factor, and phorbol esters in PC12 pheochromocytoma cells.
J. Biol. Chem. 264: 8646-8652, 1989.
53. HELLER , T. , M. KOCHER , J. NEUMN , W. SCHMITZ , H.
SCHOLZ , V. STEMMILDT , and K. STORTZEL. Effects of adeno-
sine analogues on force and cAMP in the heart. Influence
of adenosine deaminase. Eur. J. Pharm. 164:179-187 , 1989.
54. HENRICH , M. , H. M. PIPER , and J. SCHRADER. Evidence
for adenylate cyclase-coupled A -adenosine receptors on
ventricular cardiomyocytes from adult rat and dog heart.
Life Sci. 41:2381-2388 , 1987.
. J
142
55. HIGH, C. W. , and J. T. STULL. Phosphorylati of myosin
in perfused rabbit and rat hearts. Am. J. Phvsiol. 239:H756-
H762 , 1980.
56. HOLROYDE , M. J., D. A. SMALL , E. HOWE , and R. J. SOLARO.
Isolation of cardiac myofibrils and myosin light chains
with in vivo levels of light chain phosphorylation. Bioch.
BiophVs. Acta 587: 628-637, 1979.
57. HUGGINS, J. , E. A. COOK , J. R. PIGGOT , T. J. MATTINS-
LEY , and P. J. ENGLAND. Phospholamban is a good substrate
for cyclic GMP-dependent protein kinase in vitro, but not
in intact cardiac or smooth muscle. 
Bioch. J. 260:829-835,
1989.
58. HUNTER, T., N. LING, and J . A. COOPER. Protein kinase
C phosphorylation of the EGF receptor at a threonine
residue close to the cytoplasmic face of the plasma mem-
brane. Nature 311:480-483 , 1984.
59. IWASA, Y., and M. M. HOSEY. Phosphorylation of cardiac
sarcolemmal proteins by the calcium-activated phospholip-
id-dependent protein kinase. 
J. Biol. Chem. 259: 534-540
1984.
60. JACOBSON, S. L. Techniques for the isolation and
culture of adult cardiomyocytes. In: Isolated adult cardi-
omvocvtes: structure and metabolism edited by PIPER, H.
and G. ISENBERG). Boca Raton:CRC Press , 1989 , p. 43-80.
143
61. JAKOBS , K. H. , M. MINUTH , S. BAUER , R. GRANDT, 
GREINER , and P. ZUBIN. Dual regulation of adenylate cy-
clase. A signal transduction mechanism of membrane recep-
tors. Basic Res. Cardiol. 81:1-9 , 1986.
62. JEACOCKE, SA , and P. J. ENGLAND. Phosphorylation of a
myofibrillar protein of M 150, 000 in perfused rat heart
and the tentative identification of this as c-protein.
FEBS Letters 122: 429-432, 1980.
63. JOHNSON , J. D. , E. J. EHABBAZA, B . L. BAILEY, and T. J .
GRIESHOP. Calcium binding proteins in the regulation of
muscle contraction. In: Cardiac muscle: The requlation of
excitation and contraction , ( edited by NATHAN , R.
Orlando:Academic Press , 1986 , p. 297-313.
64. JONES , L. R., H. R. BESCH JR. , J. W. FLEMING , M.
MCCONNAUGHEY, and A. M. WATANABE. Separation of vesicles of
cardiac sarcolemma from vesicles of cardiac sarcoplasmic
reticulum. J. Biol. Chem. 254: 530-539 , 1979.
65. KAMEYAM, M. , J. HESCHELER, F. HOFMANN, and W. TRAUT-
WEIN. Modulation of a calcium current during the phospho-
rylation cycle in the guinea pig heart. Pflueqers Arch.
4 07 : 12 3 -112 8, 198 6 . . pa
66. KATZ , A. M. Role of contractile proteins and sarco-
plasmic reticulum in the response of the heart to catecho-
lamines: An historical review. In: Advances in cyclic
66. KATZ , A. M. Role of contractile proteins and sarco-
plasmic reticulum in the response of the heart to catecho-
lamines: An historical review. In: Advances in cyclic
nucleotide research , (edited by GREENGARD, P., and G.
ROBISON). New York:RaVen Press , 1979, p. 303-343.
67. KATZ, A. , R. A. COLVIN, and T. ASHAVID. Phospho lam-
ban and calciductin. J. Mol. Cell. Card. 15:262-264 , 1983.
68. KATZ , A. M., M. TADA , and M. A. KIRCHBERGER. Control of
calcium transport in the myocardium by the cyclic AMP-
protein kinase system. Adv. Cyc. Nuc. Res. 5:453-477
1975.
69. KEELY , S. L., J. D. CORBIN , and C. R. PARK. Regulation
of adenosine 3 I : 5 I -monophosphate dependent protein kinase.
J. Biol. Chem. 250:4832-4840 , 1975.
70. KEMP , B. , D. J. GRAVES , and E. BENJAMINI. Role of
multiple basic residues in determining the substrate
specificity of cyclic AMP-dependent protein kinase.
J. BioI. Chem. 252:4888-4894, 1977.
71. KENT, L. , D. L. MANN , Y. ARABE , R. HISANO , K.
HEWETT , M. LOUGHNANE , and G. IV COOPER. Contractile func-
tion of isolated feline cardiocytes in response to viscous
loading. Am. J. Ph siol. 257:H1717-H1727 , 1989.
144
72. KIRCHBERGER , M. A., M. TADA , and A. M. KATZ. Adenosine
3 I : 5. -monophosphate-dependent protein kinase catalyzed
phosphorylation reaction and its relationship to calcium
transport in cardiac sarcoplasmic reticulum. 
J. Biol. Chem.
249: 6166-6173, 1974.
73. KRANIAS, E. , J. L. GARVEY , R. D. SRIVASTAVA, and R.
SOLARO. Phosphorylation and functional modifications of
sarcoplasmic reticulum and myofibrils in isolated rabbit
hearts stimulated with isoprenaline. Bioch. J. 226: 113-
121 , 1985.
74. KRAUSE , E. -G., S. BARTEL, I. BEYERDORFER, W. FREIER,
K. GERBER, and D. OBST. Transient changes in cyclic AMP
and in the enzymic activity of protein kinase and phospho-
rylase during the cardiac cycle in the canine myocardium
and the effect of propanolol. 
Mol. Cell. Bioch. 89: 181-
186, 1989.
75. KREBS , E. , and J. A. BEAVO. Phosphorylation-dephosp-
horylation of enzymes. 
Ann. Rev. Bioch. 48:923-959, 1979.
76. KREBS , E. G., D. J. GRAVES , and E. H. FISCHER. Factors
effecting the activity of muscle phosphorylase b kinase.
J. Biol. Chem. 234: 2867-2873, 1959.
77. KUO , J. , R. C. SCHATZMAN , R. S. TURNER, and G.
MAZZEI . PhOspholipid-sensitive ca
2+ 
-dependent protein
kinase: a major protein phosphorylatio system. Mol. Cell.
Endocrin. 35: 65-73, 1984.
145
146
78. LAEMMLI , U. K. Cleavage of structural proteins during
the assembly of the head of bacteriophage T4. Nature
227: 680-685, 1970.
79. LANGER , G. A. Heart: excitation-contraction coupling.
Ann. Rev. Ph siol. 35:55-92 , 1973.
80. LEUNG , E., C. I. JOHNSTON , and E. A. WOODCOCK. stimula-
tion of phosphatidylinositol metabolism in atrial and
ventricular myocytes. Life Sci. 39:2215-2220, 1986.
81. LIANG , B. , and J. B. GALPER. Differential sensitivi-
ty of ' 0 and ' i to ADP-ribosylation by pertussis toxin in
the intact cultured embryonic chick ventricular myocyte.
Bioch. Pharm. 37:4549-4555, 1988.
82. LINDEMANN , J. P., L. R JONES , D. R. HATHAWAY , B. G.
HENRY and A. M. WATANABE. a-adrenergic stimulation of
phospholamban phosphorylation and Ca 2+ -ATPase activity in
guinea pig ventricles. J. BioI. Chem. 258:464-471, 1983.
83. LINDEMANN , J. , and A. M. WATANABE. Muscarinic choli-
nergic inhibition of b-adrenergic stimulation of phospho-
lamban phosphorylation and Ca2+ transport in guinea pig
ventricles. J. BioI. Chem.. 260:13122-13129 1985.
84. LINDEN, J., C. E. HOLLEN , and A. PATEL. The mechanism
by which adenosine and cholinergic agents reduce contrac-
tility in rat myocardium. Circ. Res. 56:728-735 , 1985.
147
85. LOWRY , O. , N. J. ROSEBROUGH , A. J. FARR, and R.
RANDALL. Protein measurement with the Folin phenol re-
agent. J. Biol. Chem. 193:263-275 , 1951.
86. MAEDA, A., T. KUBO, M. MISHINA , and S. NUM. Tissue
distribution of mRNAs encoding muscarinic acetylcholine
receptor subtypes. FEBS Letters 239: 339-342, 1988.
87. MANGANELLO, V. C. Subcellular localization and biolog-
ical function of specific cyclic nucleotide phosphodies-
terases. J. Mol. Cell. Card. 19:1037-1040 , 1987.
88. MARTEN , D. , M. !. LOHSE , and V. SCHWABE. Pharmacologi-
cal characterization of Ai adenosine receptors in isolated
rat ventricular myocytes. Naunyn-Schmiedeberq' s Arch.
Pharmacol. 336:342-348 , 1987.
89. MCGILVERY , R. W., and T. W. MURRAY. Calculated equili-
bria of phosphocreatine and adenosine phosphate during
utilization of high energy phosphate by muscle. J. BioI.
Chem. 249: 5845-5850 , 1974.
90. MEYER , F. , L. M. HEILMEYER , R. H. HASCHKE , and E.
FISCHER. Control of phosphorylase activity in a muscle
glycogen particle I. J. Biol. Chem. 245: 6642-6648 , 1970.
91. MEYER, W., M. NOSE , W. SCHMITZ , and H. SCHOLZ. Adeno-
sine and adenosine analogs inhibit phosphodiesterase
activity in the heart. Naun n-Schmiedeber s Arch. Pharma-
col. 328: 207-209 , 1984.
148
92. MEYER , W. , E. H. FISCHER , and E. G. KREBS. Activation
of skeletal muscle phosphorylase b kinase by calcium.
Biochemistry 3: 1033-1039 , 1964.
93. MILLER , T. B. Phosphorylase activation hypersensitivi-
ty in hearts of diabetic rats. Am. J. Phvsiol. 246:E134-
96. NIMMO , G. A., and P. COHEN. The regulation of glycogen
E140 , 1984.
94. MIYAKODA, G. , A. YOSHIDA , H. TAKISAWA , and T. NAKAMU-
RA. a-adrenergic regulation of cardiac contractility and
protein phosphorylation in spontaneously beating isolated
rat myocardial cells. J. Bioch. 102: 211-224 , 1987.
95. MORGAN, M. , S. V. PERRY, and J. OTTAWAY. Myosin light
chain phosphatase. Bioch. J. 157:687-697, 1976.
metabolism: phosphorylation of inhibitor-1 from rabbit
skeletal muscle , and its interaction with protein phospha-
tases -III and -II. Eur. J. Biochem. 87:353-361 , 1978.
97. ONARATO , J. J ., and S. A. RUDOLPH. Regulation of pro-
tein phosphorylation by inotropic agents in isolated rat
myocardial cells. J. Biol. Chem. 256: 10697-10703 , 1981.
98. OSTERRI EDER , W. , G. BRUM , F. HESCHELOR, W. TRAUTWEIN,
V. FLOCKERZI, and F. HOFFMANN. Inj ection of subunits of
cyclic AMP-dependent protein kinase into cardiac myocytes
modulates calcium current. Nature 298: 576-570 , 1982.
149
99. PEARSON , R. , J. R. WOODGETT , P. COHEN , and B.
KEMP. Substrate specificity of a multifunctional calmodu-
lin-dependent protein kinase. J. Biol. Chem. 260:14471-14476,
1985.
100. PERRIE, W. , L. B. SMILLIE, and S. V. PERRY. A phosp-
horylated light chain component of myosin from skeletal
muscle. Bioch. J. 135:151-162, 1973.
101. PRASHAD , N. Reduced levels of cardiac cAMP-dependent
protein kinase in spontaneously hypertensive rat. J. BioI.
Chem. 260: 10125-10131 , 1985.
102. PRESTI , C. , L. R. JONES , and J. P. LINDEMANN. Iso-
proterenol-induced phosphorylation of a 15-kilodalton
sarcolemmal protein in intact myocardium. J. BioI. Chem.
260: 3860-3867, 1985.
103. PRESTI , C. F., B. T. SCOTT, and L. R JONES. Identifica-
tion of an endogenous protein kinase c acti vi ty and its
intrinsic 15-kilodalton substrate in purified canine
cardiac sarcolemmal vesicles. J. BioI. Chem. 260: 13879-13889
1985.
104. RAEYMAEKERS , L. , F. HOFMANN, and R. CASTEELS. Cyc 
GMP-dependent protein kinase phosphorylates phospholamban
in isolated sarcoplasmic reticulum from cardiac and smooth
muscle. Bioch. J. 252:269-273, 1988.
150
105. RAPUNDALO , S. T. , R. J. SOLARO , and E. G. KRANIAS.
Inotropic responses to isoproterenol and phosphodiesterase
inhibi tors in intact guinea pig hearts: comparison of
cyclic AMP levels and phosphorylation of sarcoplasmic
reticulum and myofibrillar proteins. Circ. Res. 64:104-
inhibi tory subunit of troponin and its effect on the
111 , 1989.
106. RASMUSSEN , H. Cell communication, calcium ion and
cyclic adenosine monophosphate. science 170:404-409 , 1970.
107. RAY , K. P. , and P. J. ENGLAND. Phosphorylation of the
calcium dependence of cardiac myofibril adenosine triphos-
phate. FEBS Lett 70:11-20, 1976.
108. RESINK , T. J. , and W. GEVERS. Dephosphorylation of
myofibrillar proteins in actomyosin preparations and in
isolated perfused rat hearts after a-agonist withdrawal.
J. Mol. Cell. Card. 14:329-337, 1982.
109. REUTER , H. Exchange of calcium ions in the mammalian
myocardium: mechanisms and physiological significance.
Circ. Res. 34:599-612 , 1974.
110. RINALDI , M. L. , J. -P. CAPONY , and J. G. DEMAILLE. The
cyclic AMP-dependent modulation of cardiac sarcolemmal
slow calcium channels. J. Mol. Cell. Cardiol. 14: 279-289
1982.
.".
151
111. ROBISHAW , J. , and K. A. FOSTER. Role of G proteins
in the regulation of the cardiovascular system. Ann. Rev.
Phvsiol. 51:229-244 , 1989.
1990.
112. ROMANO , F. D., S. G. MACDONALD , and J. G. DOBSON, Jr.
Adenosine receptor coupling to adenylate cyclase of rat
ventricular myocyte membranes. 
Am. J. Phvsiol. 257: H1088-
H1095, 1989.
113. ROSKOSKI, JR., R. Assays of Protein Kinase. Methods
in Enzvmoloqv 99:3-6 , 1983.
114. SAEKI, Y., K. SHIOZAWA, K. YANAGISAWA, and T. SHIBA-
TA. Adrenaline increases the rate of cross-bridge cycling
in rat cardiac muscle. J. Mol. Cell. Card. 22:454-460
115. SCHMIDT, K., and W. R. KUKOVETZ. Mediation of cardiac
effects of forskolin by specific binding sites.
J. Cardiol. 13:353-360 , 1989.
116. SCHRADER , J. , R. RUBIO , and R. M. BERNE. Inhibition of
slow action potentials of guinea pig atrial muscle by
isolated cell models in cardiovascular research. In:
adenosine: a possible effect on calcium influx. J. Mol.
Cell. Cardiol. 7:427-433, 1975.
117. SEVERS, N. J. constituent cells of the heart and
Isolated adult cardiomvocytes edited by PIPER, H. M., and
G. ISENBERG. Boca Raton:CRC Press, 1989, p. 3-42.
152
118. SNEDCOR, G. , and W. G. COCHRAN. One-way classifica-
tions. Analysis of variance. In: statistical methods
(edi ted by SNEDCOR, G. W. ) Ames: Iowa state Uni versi ty
Press, 1967 , p. 258-298.
119. SOLARO, R. J. Overview of the role of Ca2+ and protein
phosphorylation in the contraction of the heart. In:
Protein phosphorylation in heart muscle , ( edited by SOLA-
, R. J. Boca Raton:CRC Press , 1986 , p. 1-17.
120. SPERALAKIS , N. Regulation of calcium slow channels of
cardiac muscle by cyclic nucleotides and phosphorylation.
J. Mol. Cell. Cardiol. 20: 75-105 , 1988.
121. SPERELAKIS, N., and G. M. WAHLER. Regulation of calci-
um influx in myocardial cells by beta adrenergic recep-
tors , cyclic nucleotides , and phosphorylation. Mol. Cell.
Bioch. 82: 19-28, 1988.
122. STULL , J . T., C. O. BROSTROM, and E. G. KREBS. Phospho-
rylation of the inhibitor component of troponin by phosp-
horylase kinase. J. Biol. Chem. 247:5272-5279 , 1973.
123. STULL, J. , and S. E. MAYER. Biochemical mechanisms
of adrenergic and cholinerqic requlation of myocardial
contractility . Washington C. : American Physiological
society, 1979, p. 171-229.
153
124. SUTHERLAND, E. , and T. W. RALL. Fractionation and
characterization of a cyclic adenine nucleotide formed by
tissue particles. J. Biol. Chem. 232: 1077-1091 , 1958.
125. SUTHERLAND , E. W. , and T. W. RALL. The relation of
adenosine 3' 5' -phosphate and phosphorylase to the actions
of catecholamines and other hormones. Pharm. Rev. 12: 265-
271 , 1960.
126. TADA , M., M. YAMADA , M. KADOMA, M. INUI, and 
OHMORI. Calcium transport by cardiac sarcoplasmic reticu-
lum and phosphorylation of phospholamban. 
Mol. Cell.
acetylcholine. Pflueqers Arch. 361:207-218 , 1976.
Bioch. 73: 46-52 , 1982.
127. TAKAI , Y., A. KISHIMOTO, Y. IWASA , Y KAWAHARA, T.
MORI, and Y. NISHIZUKA. Calcium-dependent activation of a
multifunctional protein kinase by membrane phospholipids.
J. Biol. Chem. 254:3642-3649, 1979.
128. TANEICK, R. , H. NAWRATH , T. F. MCDONALD , and W. TRAUT-
WEIN. On the mechanism of the negative inotropic effect of
129. TERASAKI, W. L. , and G. BROOKER. Cardiac adenosine
I, \
3' : 5 '-monophosphate. J. Biol. Chem. 252: 1041-1050 , 1977.
130. THOMPSON, C. , R. RUBIO , and R. M. BERNE. Changes in
adenosine and glycogen phosphorylase activity during the
cardiac cycle. Am. J. Phvsiol. 238:H389-H398 , 1980.
154
131. TOMLINS , B., S. E. HARDING , M. S. KIRBY, P. A. POOLE-
WILSON , and A. J. WILLIAMS. contamination of cardiac sarco-
lemmal preparation with endothelial membrane. 
Biochem.
BioPhys. Res. Commun. 856:137-143 , 1986.
132. TSIEN, R. W. cyclic AMP and contractile activity in
the heart. Adv. Cyc. Nuc. Res. 8:363-372, 1977.
137. WIKMAN-COFFELT, J., R. SEIVERS, R. J. COFFELT , and
133. WALSH, D. A., J. P. PERKINS, and E. G. KREBS. An adeno-
sine 3' 5' -monophosphate-dependent protein kinase from
rabbit skeletal muscle. J. Biol. Chem. 243:3763-3770, 1968.
134. WALSH , K. B., and R. S. KASS. Regulation of a heart
potassium channel by protein kinase A and C. science
242: 67-69 , 1988.
135. WEGENER , A. D., and L. R. JONES. Phosphorylation- in-
duced mobility shift in phospholamban in sodium dodecyl
sulfate-polyacrylamide gels. J. BioI. Chem. 259: 1834-1841
1984.
136. WEST, G. A., G. ISENBERG, and L. BELARDINELLI. Antago-
nism of forskolin effects by adenosine in isolated hearts
and ventricular myocytes. Am. J. Ph siol. 250:H769-H777
1986.
W. PARMLEY. The cardiac cycle: Regulation and energy
oscillations. Am. J. Ph siol. 245:H354-H362, 1983.
155
138. WOLLEBEN, C. , S. R. JASPERS , and T. B. , JR. MILLER.
Use of adult rat cardiomyocytes to study cardiac glycogen
metabolism. Am. J. Ph siol. 252:E673-E678 , 1987.
139. WOLLEBEN , C. D., R. K. MCPHERSON , J. RULFS, G. L. JOHN-
SON, and T. JR. MILLER. Phosphorylation of rat heart
glycogen synthase in cardiomyocytes and in vitro phospho-
rylations with cAMP-dependent protein kinase and protein
phosphatase-i. Bioch. Bio s. Acta 928: 98-106, 1987.
140. WOLLENBERGER, A. , E. B. BABSKII , E. -G. KRAUSE, 
GENZ, D. BLOHM, and E. V. BOGDAN OVA . Cyc 1 ic changes in
levels of cyclic AMP and cyclic GMP in the frog myocardium
during the cardiac cycle. Bioch. Bio s. Res. Comm.
55: 446-452, 1973.
141. WOODCOCK, E. , E. LEUNG, and J. MCLEOD. A comparison
atria and ventricles. Eur. J. Pharm. 133:283-289, 1987.
of muscarinic acetylcholine receptors coupled to phosphoi-
nositol turnover and to adenylate cyclase in guinea-pig
142. YAMSHITA, A., T. KUROKAWA, K. HIGASHI, T. DAN'URA
and S. ISHIBASHI. Forskolin stabilizes a functionally
coupled state between activated guanine nucleotide-binding
stimulatory regulatory protein, NS, and catalytic protein
of adenylate cyclase system in rat erythrocytes. Biochem.
Bio s. Res. Commun. 137: 190-194, 1986.
156
143. YATANI, A., and A. M. BROWN. Rapid beta-adrenergic
modulation of cardiac calcium channel currents by a fast G
protein pathway. Science 245: 71-74, 1989.
144. YUAN, S. , and A. K. SEN. Characterization of the
membrane-bound protein Xinase C and its substrate proteins
in canine cardiac sarcolemma. Bioch Biophvs Acta 886: 152-
161 1986.
